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SUMMARY 
 
  
Contagious Bovine Pleuropneumonia (CBPP) is one of the serious 
threats to the livestock in Unity State, Southern Sudan. 
This study was carried out to asses the prevalence, distribution and 
importance of CBPP using serology and participatory epidemiology methods 
so as to provide useful information which support the surveillance and 
control strategies of the disease in Unity State. 
Eight  bovine  lung tissue samples were been cultured to isolate the 
Mmm organism and total of 600 serum samples were collected from 
different locations in Unity State and have been tested by using two 
serological tests; Complement Fixation Test (CFT) and Competitive Enzyme 
Linked Immuno Sorbent Assay (c-ELISA). 
The results showed that the rate of positive reactors was 26% by CFT 
and 16.5% by c-ELISA.  
The CFT was found to be more successful in the diagnosis of CBPP 
but was found to be more complicated to be applied at the field as well. 
The Competitive ELISA was found to be useful and straight forward 
but showed high range of doubtful results in comparison with CFT. 
The Participatory Epidemiology Approaches result among Nuer and 
Messeria groups indicated that those communities have a useful knowledge 
about the disease which supports the disease surveillance and control. 
 
 
 
 
 ﻣﻠﺨﺺ اﻟﻸﻃﺮوﺣﺔ
 
 
ﻣﺮض ذات اﻟﺮﺋﺔ اﻟﺴﺎري ﻓﻲ اﻷﺑﻘﺎر ﻳﻤﺜﻞ أﺣﺪ اﻟﻤﻬﺪدات اﻟﺨﻄﻴﺮِة ﻟﻘﻄﺎع اﻟﻤﺎﺷﻴِﺔ ﻓﻲ وﻻﻳﺔ 
  .اﻟﻮﺣﺪِة، ﺟﻨﻮب اﻟﺴﻮدان
هﺪﻓﺖ هﺬﻩ اﻟﺪراﺳِﺔ ﻟﻤﻌﺮﻓﺔ ﻣﻌﺪل إﻧﺘﺸﺎَر وﺗﻮزﻳَﻊ وأهﻤﻴَﺔ ﻣﺮض ذات اﻟﺮﺋﺔ اﻟﺴﺎري ﻓﻲ 
ﻴﺔ وﻃﺮق ﻋﻠِﻢ اﻷوﺑﺌﺔ ﺑﻤﺸﺎرآﺔ اﻟﻤﺠﺘﻤﻌﺎت اﻟﺮﻋﻮﻳﺔ ِﻟﻜﻲ ُﺗﺰّودﻧَﺎ اﻷﺑﻘﺎر ﻋﻦ ﻃﺮﻳﻖ اﻷﺧﺘﺒﺎرات اﻟﻤﺼﻠ
ﺑﺎﻟﻤﻌﻠﻮﻣﺎَت اﻟﻼزﻣﺔ اﻟﺘﻲ َﺗْﺪﻋُﻢ اﻟﺘﻘﺼﻲ اﻟﻤﺮﺿﻲ و اﺳﺘﺮاﺗﺠﻴﺎت اﻟﺴﻴﻄﺮُة ﻋﻠﻰ اﻟﻤﺮِض ﻓﻲ وﻻﻳِﺔ 
 .ﺟﻨﻮب اﻟﺴﻮدان، اﻟﻮﺣﺪِة
  ﺗﻢ ﺟﻤﻊ آﻤﺎﻓﻲ هﺬا اﻟﺒﺤﺚ ﺗﻢ أﺳﺘﺰراع ﺛﻤﺎن ﻋﻴﻨﺎت ﻣﻦ ﻧﺴﻴِﺞ اﻟﺮﺋﺔ ﻟَﻌْﺰل اﻟﻤﺴﺒﺐ اﻟﻤﺮﺿﻲ
 ﻋﻴﻨِﺔ ﻣﺼِﻞ  ِﻣْﻦ ﻣﻨﺎﻃﻖ ﻣﺨﺘﻠﻔِﺔ داﺧﻞ وﻻﻳﺔ اﻟﻮﺣﺪِة وﺗﻢ إﺧﺘﺒﺎرهﺎ ﺑﺈﺳﺘﻌﻤﺎل إﺛﻨﺎن ﻣﻦ اﻹﺧﺘﺒﺎراَت 006
أوﺿﺤﺖ اﻟَﻨﺘﺎِﺋَﺞ ﺑﺄّن ، (ASILE-c) و أﺧﺘﺒﺎر اﻷﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻲ  )TFC(اﻟﻤﺼﻠﻴﺔ؛ أﺧﺘﺒﺎر ﺗﺜﺒﻴﺖ اﻟﻤﺘﻤﻢ
ِﻣﻦ ِﻗﺒﻞ إﺧﺘﺒﺎراﻷﻟﻴﺰا  %( 5.61)وﺑﺈﺧﺘﺒﺎِر  ﺗﺜﺒﻴﺖ اﻟﻤﺘﻤﻢ %( 62 )ﻧﺴﺒَﺔ اﻟﺘﻔﺎﻋﻼِت اﻹﻳﺠﺎﺑﻴِﺔ َآﺎﻧْﺖ
 .اﻟﺘﻨﺎﻓﺴﻲ
 وﻟﻘﺪ دﻟﺖ اﻟﻨﺘﺎﺋﺞ ﻋﻠﻲ أن اﺧﺘﺒﺎر ﺗﺜﺒﻴﺖ اﻟﻤﺘﻤَﻢ أآﺜَﺮ ﻧﺠﺎﺣًﺎ ﻓﻲ ﺗﺸﺨﻴِﺺ ﻣﺮض ذات اﻟﺮﺋﺔ 
  .اﻟﺴﺎري ﻓﻲ اﻷﺑﻘﺎر وﻟﻜﻦ ﻟﻮﺣﻆ أن اﻹﺧﺘﺒﺎَر أﺷﺪ ﺗﻌﻘﻴﺪا َﺑﺤﻴﺚ ﻳﻌﻴﻖ اﻟﺘﻨﻔﻴَﺬ ﻋﻠﻲ ﻣﺴﺘﻮى اﻟﺤﻘِﻞ
ﺘﺎﺋﺞ ﻣﻘﺒﻮﻟﺔ و ﻣﻔﻴﺪَة وﻣﺒَﺴﻄﺔ ﻟﻜﻦ ﻟﻮﺣَﻆ أن ﻧ(  )ASILE-cﺣﻘﻖ أﺧﺘﺒﺎراﻷﻟﻴﺰا اﻟﺘﻨﺎﻓﺴﻲ 
 .هﻨﺎﻟﻚ ﻣﺪى ﻋﺎﻟَﻲ ِﻣْﻦ اﻟَﻨﺘﺎِﺋِﺞ اﻟﻐﻴﺮ ﻣﺆآﺪِة ﻣﻘﺎرﻧﺔ ﺑﺎﻟﻨﺘﺎﺋِﺞ اﻟﻤﺘﺤﺼﻠﺔ ﻣﻦ إﺧﺘﺒﺎِر ﺗﺜﺒﻴﺖ اﻟﻤﺘﻤﻢ
دﻟﺖ اﻟﻨﺘﺎﺋﺞ اﻟﻤﺴﺘﺨﻠﺼﺔ ﻣﻦ ﻣﺠﻤﻮﻋﺎت اﻟﻨﻮﻳﺮ واﻟﻤﺴﻴﺮﻳﺔ ﻋﺒﺮ ﻋﻠُﻢ اﻷوﺑﺌﺔ اﻟﺘﺸﺎرآُﻲ ﺑﺄن ﻟﻬﺬﻩ 
ﻴﻄﺮﻳﺔ ﻗﻴﻤﺔ و ﻣﻔﻴﺪة ﻓﻲ ﻣﺠﺎﻟﻰ اﻟﻤﺮاﻗﺒِﺔ واﻟﺴﻴﻄﺮة ﻋﻠﻲ ﺑ اﻟﻤﺠﻤﻮﻋﺎت اﻟﺮﻋﻮﻳﺔ ﺣﺼﻴﻠﺔ ﻣﻌﺮﻓﻴﺔ
 .اﻟﻤﺮِض
 
 
 
 
                      
   
INTRODUCTION 
 
CBPP is caused by Mycoplasma mycoides subspecies mycoides SC 
(Small Colony, variant) (Mmm SC). The disease is present in West, Central, 
East and parts of Southern Africa but not North Africa. From a historical 
perspective, CBPP was a disease of Europe and Asia. A comprehensive 
historical account of the spread of CBPP in view of the economic 
significance of the disease in Europe and Africa in the 19th century has been 
provided by Windsor (1977). With the near eradication of Rinderpest in 
Africa (except the Somali ecosystem), CBPP has become the most 
significant epidemic disease of cattle in Africa with 22 countries reporting 
outbreaks of 
the disease in 2003.  
CBPP has been a major cause of cattle mortality and production losses 
in many parts of Africa. Being an OIE List A disease and with implications 
for rapid spread between herds and across international borders, CBPP has 
engaged the attention and resources of the FAO for many years in attempts 
to curb the spread of the disease and limit its devastating economic effects, 
especially at the village or community level. CBPP is an economically 
important, contagious respiratory disease of cattle that affects domestic 
ruminants of the genus Bos, mainly Bos taurus and Bos indicus. CBPP has 
become a serious obstacle to livestock development in sub-Saharan Africa 
and Asia. It is characterized by a morbidity rate of 75%–90%, a mortality 
rate from 50% to 90%, and a case-fatality rate of 50%. 
In the Sudan the disease has been enzootic since the beginning of this 
century and is now presented in all states except the Eastern and Northern 
States (Anon, 1969).  
 The similarity of CBPP with other forms of pneumonia (Hudson, 1971) 
makes it difficult for veterinarian in the field to reach a conclusive diagnosis 
on clinical symptoms only (Abdulla, 1975). These problems will adversely 
affect the quick control measures to be undertaken in case of CBPP 
outbreaks. Further more no single serological test is 100% accurate in 
diagnosis the disease (Shifirine and Gourlay, 1967). Even the complement 
fixing test gave 6% false positive reactors (Gourlay, 1965). 
 
The aim of this study was to accomplish a potential database to asses 
the prevalence, distribution and importance of Contagious Bovine 
Pleuropneumonia (CBPP) in Unity State, Southern Sudan. The study also 
aimed to evaluate and compare the current CBPP serological tests (CFT and 
c-ELISA) in both sensitivity and viability at the field levels.  
The study also aimed to practice participatory epidemiology techniques for 
qualitative epidemiological intelligence in the disease surveillance.  
The study intended to participate in the surveillance and control strategies 
for CBPP by establishing Early Warning System indicators.  
 
 
 
 
 
 
 
 
 
CHAPTER ONE 
 LITERATURE REVIEW 
 
1.1.  Definition: 
Contagious Bovine Pleuropneumonia (CBPP) is a devastating disease 
of cattle and water buffaloes caused by Mycoplasma mycoides subsp. 
mycoides (M.myciodes) (Turner, 1959 and Hudson, 1971). Naturally CBPP 
is an essential disease of cattle and buffalos (Turner; 1954, Lloyd; 1970 and 
Hudson; 1971). 
 
1.2. History of the disease: 
CBPP appears to have existed in the ancient world according to early 
classical writings (Provost et al., 1987). It was referred to as Polmonera by 
Gallo. 
At the end of 18th century (CBPP) could be distinguished from other 
respiratory diseases as a distinct disease caused by M. mycoides Small 
Colony (MmmSC). Evidence based on clinical, epidemiological and 
pathological information suggested a long history of the disease, Hudson 
(1965) reported that the disease originated in Europe and was disseminated 
widely by transboundary trade in livestock. Foster (1934) stated that the 
disease first appeared in Switzerland and Germany from where it spread to 
different European countries probably during the Napoleon wars. 
According to Currason; (1967) the disease was first observed in Italy 
and France in the middle of the sixteenth century.  
The disease was reported in the United States of America in 1843 (Jasper, 
1967). The disease was carried by sea to Australia through infected cattle 
from Europe in 1858 (Turner, 1959).  
Later the disease was introduced in Africa; South Africa became infected in 
1854 from either Britain (Hutyra et al., 1938) or Netherlands (Provost et al., 
1987).  
Due to strict control measures undertaken at the end of  the 19th 
century and at the beginning of the 20th century the disease was eradicated  
from most of the European countries England (1898), Russia (1940) and 
from the United States of America (1852)  (Jasper, 1967). Later some cases 
of the disease were reported in Poland in (1936) and Spain (1959) as 
mentioned by Viettoz (1969). The later cases of the disease in Europe were 
registered in France in (1973), Anon; (OIE Report, 1974). 
However in recent years there have been outbreaks of the disease in Spain, 
Portugal, and Italy (Nicholas, and Bashiruddin. 1995). It is thought to exist 
in the Middle East and Asia (Nicholas, and Bashiruddin; 1995). 
The disease is still present in most African countries south of the Sahara, 
Angola, India and China (Hudson, 1971). 
 
1.3. A etiology: 
           CBPP is caused by the organism now classified as (M.mycoides) 
strain PG-1 by Edward and Freundt (1956). 
Later this strain was classified into small and large colony types on the basis 
of growth and biochemical characteristics (Cottew and Yeast, 1978). The 
bovine strains belong to the small colony type, they do not digest casein, do 
not liquefy coagulated serum and survive for a shorter time at 45◦ C than the 
caprine large colony type.   
1.3.1. Classification of the causative Agent: 
Mmm Small Colony type, the causative agent of CBPP belongs to:  
Class; Mollicutes, Order; Mycoplasmatales, Family; Mycoplasmataceae 
and Genus; Mycoplasma (Edward and Freundt., 1969) 
MmmSC is a member of the M.mycoides cluster which includes: 
M.mycoides large colony type (MmmLC), M.capricolum subsp. capricolum 
(Mcc), M. capricolum subsp. capripeumoniae (Mccp), 
M. mycoides subsp. capri (Mm. capri) and Mycoplasma sp. bovine group 7. 
There is only one serotype of MmmSC. The six Mycoplasmas share 
the same serological and genetic characteristics and this causes taxonomic 
and diagnostic problems (Cottew, Beard, Damassa et al. (1987). 
 
1.3.2. The Agents: 
MmmSC strains cause (CBPP) in cattle and buffalo (Edward and 
Freundt, 1956) and (Provost, Perreau, Breard, Le Golf, Martel, and Cottew 
1987). 
 
1.3.2.1. Morphology:  
The organism was described as pleomorphic occurring as round, 
ovoid, ring and filamentous forms in liquid media. On solid medium the 
colonies have dark centers and light periphery which give them 
characteristic fried-egg appearance. M.myciodes has no cell wall (Kandler 
and Zehander, 1957; Plackett, 1959). Instead it is surrounded by three-
layered cytoplasmic membrane (Domermuth et al., 1964 and Anderson, 
1969). This organism stains well with Giemsa (Bordet, 1910), Methylene 
blue (Dienes, 1945) and other Aniline stains (Turner, 1959). In young 
cultures it tends to appear as branching filaments and in old-cultures as small 
coccal bodies. It requires cholesterol (added serum) for its growth. The 
organism is fragile, sensitive to desiccation and disinfectants and survives 
poorly outside the host (Turner, 1959). 
 
1.3.2.2. Pathogenicity: 
         The “cluster” contains six important mycoplasmas affecting ruminants: 
Two of them are pathogenic to cattle; MmmSC causes CBPP and 
Mycoplasma sp. bovine group 7 (BG-7) which may cause bovine arthritis 
and bovine mastitis (Cottew, 1960). The other four; two subspecies within 
Mycoplasma mycoides species and two subspecies within Mycoplasma 
capricolum species are responsible for goat respiratory and other diseases 
(Cottew, 1960). 
 
1.4. Epidemiology: 
Contagious bovine pleuropneumonia is naturally a disease of cattle 
and buffaloes (Turner; 1954, Llyoid; 1970 and Hudson; 1971). 
There is a considerable variation in the degree of symptoms seen in cattle 
affected with CBPP ranging from per acute through acute, sub clinical and 
chronic forms. Respiratory distress and coughing evident on stimulation of 
resting animals are the main signs of CBPP (Scudamore, 1976). 
Experimental reproduction of the disease is difficult but best achieved by 
bronchial intubations of low passage of M.mycoides.mycoides (Gourlay and 
Howard, 1982, Martel et al., 1983).  
In experimental infections; Regalla et al., (1994) reported disease 
symptoms appearing in cattle 40 days after contact with infected animals; 
these symptoms lasted for 20 days. Turner and Campbell (1937) reported a 
range of 29-58 days and Provost et al., (1987) stated 20-40 days. 
 
1.4.1. Host Range: 
Cattle of all ages are susceptible to CBPP and animals less than three 
years old are more susceptible. CBPP under natural condition occurred in 
cattle of species Bos and allied animals including buffalos, yak, bison and 
even reindeer (Hutyra, 1938); these authors also reported that goats and 
sheep were susceptible under experimental conditions. Small ruminants, in 
particular goats, have also been shown to harbor the MmmSC (Hudson et al., 
1971). Brando (1995) isolated MmmSC from the milk of sheep with mastitis, 
as well as from goats with pneumonia in Portugal outside the endemic 
region of CBPP. Dick (1937) in Australia found sheep very susceptible to 
subcutaneous inoculation, some even dying as a result of extensive reaction.  
Yak and bison have been infected in zoos, and infection has been reported in 
water buffalo (Bubalus bubalis). 
Experimental work in Australia showed that buffalo could be infected 
by artificial means but didn’t spread CBPP to in-contact buffaloes (Newton, 
1992). Smith (1967) showed that after inoculation of mice, complete 
elimination was often delayed and mycoplasmaemia was present in many 
mice for considerable period. 
Martins-Mendes (1958) isolated M.mycoides from male and female 
ticks of the species Boophilus decoloratus and Amblyomma pomposum that 
had fed on cattle suffering from natural infection with CBPP and from 
experimental subcutaneous reactions. 
European breeds seem to be more susceptible than African breeds, wild 
bovids and camels are both resistant to infection (OIE-1997). 
 
 
 
1.4.2. Transmission: 
Spread of the disease from infected to susceptible animals is mainly 
through inhalation of infected droplets which may be carried 10-20 or more 
meters by the air currents (Turner, 1959). Factors which influence the rate of 
spread of infection are closeness of contact, intensity of infection and the 
level of individual susceptibility (Turner, 1954). 
Direct contact is the principal mode of transmission. However alternative 
routes like wind-borne and indirect transmission cannot be excluded 
(Masiga et al, (1996); Regalla et al, (1996)). Other modes of infection were 
also reported; According to Masiga et al., (1972); Scundamore (1976) and 
Elmahi (1980); M.mycoides was isolated from the urine of infected animals 
and this contaminates the pasture and so causes indirect spread of the 
disease. Typical pulmonary lesions of pleuropneumonia were reported in 5 
out of 6 cattle fed fodder infected with virulent culture of M.mycooides 
(Windsor and Masiga, 1977). The organism was re isolated from all infected 
animals. Mm can pass through the placenta from the infected dams to the 
offspring (Stone, 1969).    
 
1.4.3. Incubation period: 
Time from natural exposure to overt signs of disease is variable but 
generally quite long. It has been shown that animals placed in CBPP infected 
herd may begin showing signs of disease 20 to 123 days later (Provost et., 
al; 1988). The incubation period of the natural disease may range from 5 to 
207 days although Turner and Campbell (1937) reported a range of 29-58 
days and Provost et al., (1987); stated 20-40 days. In experimental bronchial 
intubations infection, Regalla et al., (1996) reported the appearance of signs 
and serological response with 40 days after contact with intubated animals.  
1.4.4. Morbidity and Mortality:  
In Africa mortality rates are typically 10-70 % in epizootics characterized 
by low morbidity and low or non-existent mortality with the majority of 
infected cattle showing chronic lesions; (Masiga et al., 1996; Regalla; 1996), 
this is characteristic of endemic disease. This difference maybe due to the 
fact that European cattle are healthier in general, better in fed, subjected to 
less physical stress and often permanently housed through out the year 
(Nicholas and Palmer., 1994) and probably experienced strains of lower 
virulence than in Africa (Abdo et al., 1998). In Italy during the early 1990s 
CBPP forms with mild or without clinical signs were frequently observed in 
cattle with lesions of CBPP at slaughter. In infected herds mortality was 
around 2-3 % (Guadagnini et al., 1991). In typical outbreaks about 40 % of 
the exposed cattle contracted the disease and mortality among diseased cattle 
can range from 10 % to 70 %.     
 
1.4.5. Carriers Role:   
Some recovered cattle may harbour sequestra in their lungs and become a 
carrier. If stressed the walls of sequestra break down and the animal may 
become an active shedder and a source of infection. Carrier animals are 
dangerous because they frequently introduce the disease into previously 
uninfected areas. In fact most new outbreaks had been traced and found that 
carrier animals or healthy looking animals were the source of infection.  
 
1.4.6. Resistance: 
In Africa up to one third of cases that recover from acute disease become 
potential carriers. This figure is probably higher in Europe where there is far 
more widespread use of antimicrobials (Nicholas and Palmer., 1994). 
The use of antibiotics and anti-inflammatory drugs may help to mask clinical 
signs and to accelerate the formation of chronic lesions.  
 
1.4.7. Outbreaks: 
Out breaks usually begin by introducing an infected animal into a naive 
herd. It is widely believed that recovered animals harboring infectious 
organisms within a pulmonary sequestrum may become active shedders 
when stressed. Although this may be a factor in some outbreaks, it has not 
been substantiated experimentally (Windsor and Masiga, 1977).  
 
1.5. Symptoms and Signs of the disease: 
The early stages of the disease are indistinguishable from any severe 
pneumonia with pleurisy (Scudamore, 1976). 
The disease may be clinical or sub clinical, the clinical form may be acute, 
sub acute or chronic (Turner, 1959). Sub-clinical and chronic cases of CBPP 
constitute more than 50% of the animals involved in the epizootic (Bygrave 
et al., 1968). In calves about one year old or less the clinical picture of the 
disease is primarily characterized by arthritis and the chest may be free from 
any lesions (Moulton et al., 1965), Turner and Trethewie, (1961); Simmons 
and Johnson, (1963); Harbi and Salih, (1979) and Elmahi, (1980). 
 
1.5.1. Per acute form: 
The clinical signs are observed in per acute form are much accelerated. 
The pathological signs are usually characteristic with marked pleural 
adhesion accompanied by exudative pericarditis and myocarditis (Provost et 
al., 1987). Affected animals may die within a week exhibiting classical 
respiratory signs. 
1.5.2. Acute form: 
The clinical signs in the typical acute case can be summarized as follows: 
A rise in body temperature to 41◦ C, shallow and rapid respiration in the 
early stage of the disease, which soon becomes abdominal with painful 
grunting and dilation of the nostrils. The neck is extended and the animals 
stand facing the wind. There is an excess mucous in the nostrils and frothy 
saliva around the mouth and occasional soft coughs are heard (Bygrave et 
al., 1968 and Hudson., 1971). Animals show; Dullness, Anorexia, Irregular 
rumination with moderate fever (up to 40◦-42◦C) and may show signs of 
respiratory distress. Complications in calves may include valvular 
endocarditis and myocarditis (Martel et al., 1983).   
While classical respiratory signs may be evident in calves, articular 
localization of the causative agent with attendant arthritis usually 
predominates. The clinical picture of infection in many  calves is manifested 
by arthritis (Turner, 1959); the chest may be free from lung lesion even 
though the causative agent is introduced in the pulmonary system (Harbi and 
Salih, 1979, and El Mahi, 1980).  
 
1.5.3. Sub acute form:  
In sub acute cases lesions are localized in small parts of the lung, the 
position can not be easily located by percussion and auscultation. The only 
symptom is a rare cough. Sometimes new foci of infection are created and 
acute symptoms set in (Henning, 1956). In the sub acute form signs may be 
limited to a slight cough only noticeable when the animal is exerted or 
exercised.  
 
 
1.5.4. Chronic form: 
In chronic cases the only symptom is a cough which usually appears 
when the animal rises or when it suddenly passes from a warm stable to a 
cold one or when it drinks cold water (Henning, 1956). 
 
1.6. Pathology: 
1.6.1. Lesions: 
1.6.1.1. Lungs and Pleura: 
The pathological lesions of the CBPP are confined to the thoracic cavity 
and the lungs, and lesions are usually unilateral. The diaphragmatic lobe was 
observed to be more commonly affected than the cranial lobe (Nunes and 
Pestica et al., 1988; 1990). The thoracic cavity of affected animals may 
contain many liters of clear yellowish brown fluid containing some pieces of 
fibrin (Ter-Laak, 1992). This pleural fluid is the ideal diagnostic material 
from which the causative mycoplasma can be isolated from or on which 
PCR can be carried out with DNA purification (Nicholas and Bashiruddin, 
1995). Caseous fibrinous deposits are observed on the parietal visceral 
surfaces of the lungs (Provost et al., 1987). The interlobular septa of the 
affected lungs show distension with amber colored fluid surrounding the 
distended lymphatics. This fluid separates the lung lobules which vary in 
color with red, grey and yellow hepatization being evident indicating 
different stages of inflammatory lesions (Hudson, 1971). Consolidation of 
the lungs with typical marbled appearance sometimes accompanied by 
adhesions of the parietal and visceral surfaces of the pleura. Sequestrum 
consisting of necrotic lung parenchyma surrounded by a fibrous capsule 
which varies in size between 1 and 10 cm in diameter is formed in chronic or 
advanced cases (Martel et al., 1983; Trichard et al., 1989; Santini et al., 
1992). The sequestrum may constitute a source of infection to cattle when 
ruptured, particularly where the sequestrum is drained by bronchus which 
forms an outlet for dissemination of infected aerosol droplets (Provost et al., 
1987), such mechanism will account for outbreaks of disease in closed herds 
(Windsor and Masiga; 1977). 
 
1.6.1.2. Lymphnodes: 
The mediastinal and bronchial lymph nodes are swollen and juicy. On 
section the inner surface is either normal (Yellowish) congested or granular 
(Bygrave et al., 1968).  
 
1.6.1.3. Joints and Bursa:  
Lesions in calves are often restricted to the joint and bursa (Moulton et 
al, 1956; Turner and Trethewie, 1961; Simmon and Johnson, 1963; Harbi 
and Salih, 1979 and El Mahi, 1980). Turner and Trethewie (1961) described 
the lesions in the joints and bursae as non purulent serofibrinous polyarthritis 
characterized by hyperemia and effusion. In addition to respiratory disease 
affected calves may present exudative peritonitis, arthritis, bursitis and 
fibrinous arthritis of the carpal and tarsal joints (Provost et al., 1987).  
 
1.6.1.4. Kidneys: 
In kidney, sharply demarcated renal infarcts are clearly visible when the 
capsule is striped (Hudson, 1971 and El Mahi, 1980). 
 
1.6.1.5. Heart: 
In calves heart lesions were described as vegetative vulvitis, endocarditis 
and myocarditis (Turner and Trethewie, 1961). 
1.7. Diagnosis: 
 
1.7.1. Clinical diagnosis: 
Diagnosis of all forms of the disease on clinical ground alone is very 
difficult since the symptoms simulate those of other forms of pneumonia 
(Turner, 1959 and Hudson, 1971). 
 
1.7.2. Isolation of the organism: 
MmmSC grows well in both anaerobic and aerobic environments at a pH 
of 7.6-7.8. It usually grows well in sealed liquid broth cultures especially if 
the broth level is few inches deep to allow for oxygen or air gradient. Gentle 
aeration increases the growth rate and the yield of MmmSC (Rodwell and 
Mitchell, 1979). In actively growing cultures Mmm is filamentous which the 
result of genetic division preceding cytoplasmic division. At the end of 
growth however short beaded filaments predominate and ultimately only 
coccoid bodies are seen (Razin, 1978).  
The addition of serum to the medium is essential for growth (Bennett, 1932).  
Many media have been described which enable the growth of 
MmmSC for example; Bennett, 1932; Hudson, 1971; Freundt, 1983; 
Nicholas and Barker, 1998; Rice et al., 2000.  
Conventional growth media with the addition of inhibitors such as 
ampicillin, bacitracin, penicillin-G, polymyxin-B and thalium acetate to 
inhibit the growth of cell walled bacteria may be particularly useful as it 
inhibits Acholeplasma as well (Abu-Amero et al., 1996). 
The growth of arginine-hydrolysing mycoplasmas may be inhibited by 
citrulline, lysine and ornithine (Ozcan et al., 1999).  
In acute cases the causative agent can be isolated from the blood and 
nasal swabs as follow: - 
Drawn 10 ml of blood from jugular vein under sterile conditions is added to 
90 ml of liquid medium containing horse serum, penicillin and thalium 
acetate and incubated aerobically at 37◦ C for few days (Hudson, 1971). 
When turbidity is evident sub culture is made on solid medium and 
incubated aerobically at 37◦ C and examined daily for the appearance of 
mycoplasma colonies. 
If the animal has died; pleural fluid or affected lung can be collected 
aseptically for cultural examination in selective media (Gourlay, 1973). If 
putrefaction has commenced sterile filter paper can be soaked with the 
pleural fluid or allowed to absorb fluid from lung lesion (Turner, 1959). 
Since Mycoplasma rises higher by capillary than do most contaminating 
bacteria (Elbert and Peretz, 1932). 
In chronic cases cultural examination from the sequesterum in 
Mycoplasma medium usually yields  M.mycoides for differential diagnosis a 
culture of Actinobacillus is necessary (Hudson, 1971). 
 
1.7.3. Post-mortem findings: 
If the animals has died or was slaughtered the necropsy findings are 
suggestive but differentiation should be made from acute pulmonary 
pasteurellosis. A smear stained with Methyline blue or Giemsa may reveal 
bipolar Pasteurella organism (Hudson, 1971). 
In chronic cases differentiation should be made between the sequestrum and 
Echinococcus cyst. A precipitin test or isolation of the organism will 
distinguish between the two organisms (Turner, 1959 and Hudson, 1971).   
 
1.7.4.  Biochemical Tests:   
The sensitivity to digitonin indicates the requirement for sterol, members 
of the genus Mycoplasma are digitonin sensitive and this test is performed 
after the initial isolation of suspicious mycoplasmas. A series of biochemical 
tests standardized by (Aluotto et al., 1970) should follow and MmmSC 
strains may be identified by the fermentation of glucose, the reduction of 
tetrazolium aerobically and an aerobically and the digestion of casein; they 
do not hydrolyse arginin, liquify coagulated serum, produce film and spots 
and have no phosphatase activity.  
Final identification of mycoplasmas is usually achieved by growth 
inhibition (GI) and or immunofluoresence (IF) tests which are carried out on 
agar with specific antiserum. The tests are relatively specific; they can 
identify the two subspecies of M.m.mycoides but can not distinguish 
between SC and LC. 
Recently a nitro-blue tetrazolium (NBT) reduction technique has been 
described for the detection of substrate metabolism by washed cell 
suspensions and may be suitable for use in routine laboratories to 
differentiate Mmm LC, SC and Mm subsp. Capri strains (Miles, 1938). 
Bashiruddin et al., (1999) and Bashiruddin and Windsor., (1998) have 
developed a medium in which Mmm colonies were colored red due to 
tetrazolium reduction (Reigate, UK). Using clinical materials and isolated 
Mycoplasmas to inoculate plates, M.m.mycoides LC and Capri colonies 
were dark red after 3 days whereas Mmm SC colonies much lighter colored 
and only became dark red after approximately 7 days. This medium may be 
useful in the primary isolation of Mmm SC from clinical material enabling 
immediate identification of colonies for subsequent testing by standard and 
molecular methods (Bashiruddin et al., 1999c; Windsor, 1977). 
The results of substrate oxidation studies have also led to the 
development of rapid tests for the utilization of maltose and glycerol by 
members of the Mycoplasma mycoides cluster. The inability to use maltose 
differentiates MmmSC strains (32/32 strains negative) from other 
Mycoplasma mycoides strains (32/35 strains +ve). A test was developed 
based on hydrolysis of a colorless chromogenic alpha-glucoside (Maltase) 
substrate p-nitrophenyl-a-D-glucopyranoside (ρ-NBG) to give a brightly 
colored yellow product (ρ-nitro phenol). It can be carried out using cells 
washed and resuspended in buffer or by simply adding ρ-NBG (100 Mm) to 
colonies on agar plates; colonies of maltose-utilizing strains become colored 
in about 40 min (Rice et al., 2000). 
Glycerol utilizing ability leads to the production of hydrogen peroxide 
which may be detected in colorimetric assays (Houshaymi et al., 2000). 
These tests confirmed that European M.m.mycoides SC strains did not 
oxidize glycerol (i.e. there was no hydrogen peroxide produced) and the high 
rates of hydrogen peroxide production were observed for non European 
Mmm SC strains, subsp. Mycoides LC and subsp. Capri strains. In 
qualitative assay using colonies grown on serum agar (72/96h), plates were 
flooded with a reagent prepared by mixing glycerol, 3’3’ di-aminobenzidine 
and peroxidase. Plates were then incubated at 37C◦ and observed for red 
coloration of colonies. The time for development of color was 45-135 
minutes for European Mmm SC strain but 1-20 minutes for other strains of 
Mmm (Houshaymi et al., 2000). Requirement of serum and sensitivity to 
digitonin reversion both are essential for identification. 
 
 
 
1.7.5. Serological Diagnosis: 
 
1.7.5.1. Slide Agglutination Test: 
The slide agglutination test using serum (Priestly, 1951) or blood 
(Newing and Field, 1953) is sensitive in early stages of the disease and 
suitable for establishing a preliminary diagnosis when large numbers of 
cattle are involved and for selecting these cattle to be bled for CFT (Turner 
and Etheridge, 1963). This test is less suitable for detecting chronic cases 
(Parker, 1960 and Alder and Etheridge, 1964), so it is recommended to be 
used as a herd test rather in individual animal. 
 
1.7.5.2. Tube Agglutination Test: 
The tube agglutination test using a formalin-killed suspension of the 
organism was found unsatisfactory for diagnosis of some of the severe cases 
and all the carrier animals (Campbell, 1938). 
 
1.7.5.3. Precipitation Test: 
The precipitation test whether in tubes (Turner, 1962a) or agar plates 
(White, 1958) has proved to be of great value in the examination of 
suspected sequestra and other lesions (lungs and pleural fluids). This test 
may be used to detect both antibody in sera and antigen in blood, pleural 
exudates, body tissue and urine (Gourlay, 1964, 1965). The same author 
found this test as accurate as the CFT in detecting clinical signs but less 
accurate in detecting carriers. 
 
 
 
1.7.5.4. Complement Fixation Test (CFT): 
The most reliable test for detecting infected animals particularly those 
with sequestra is CFT (Campbel and Turner, 1953; Lindley, 1960; Huddart, 
1963 and Pearson and Mc Pherson, 1966). 
The advantage of the CFT is the low number of false positive and negative 
reactions (Hudson, 1971). The CFT is the approved OIE test although 
specific lacks of sensitivity. With a positive result being any reaction at 1/10 
or higher, the CFT is also not robust. In addition it requires highly trained 
staff to perform it accurately and consistently (Regalla, 1995). In a thorough 
examination of the CFT in which over 33,000 sera from healthy herds were 
tested during 1991 to 1994 in Italy, Bellini et al., (1998) had reported that 
the CFT was 98% specific, while its sensitivity based on nearly 600 cattle 
with specific lesions from 11 infected herds was only 64%. Isolation of the 
causative mycoplasma from affected animals was even more Insensitive, 
54%. It follows that by using the CFT as a screening test, some CBPP 
affected cattle, in the early or later stages of infection are likely to be missed. 
 
1.7.5.5. Enzyme Linked Immuno Sorbant Assay (ELISA): 
Recently the enzyme linked immuno sorbant assay (ELISA) was use to 
detect antibodies against MmmSC (Onoviran and Taylor Robinson, 1979). 
The ELISA was found to be more sensitive than the CFT, Slide 
agglutination serum test and agar gel test. It could detect Mycoplasma 
mycoides antibodies in sera of cattle at least 19 months of infection and 25 
months after vaccination. Indirect ELISA has been described for CBPP for 
nearly 20 years using crude antigens (Onoviran and Taylor-Robinson, 1979; 
Le Goff, 1986; Poumarat et al., 1989; Nicholas et al., 1996). All appear to 
be sensitive but may lack sensitivity. 
A blocking ELISA with monoclonal antibody which although raised 
against MmmSC nonetheless recognized all members of the cluster was 
compared with the CFT for detecting antibodies in cattle during the Italian 
CBPP eradication campaign (Mia et al., 1993). There was 96% agreement 
between the tests over 300 positive and negative sera. Nevertheless a small 
number of sera from apparently healthy herds was positive in CFT but gave 
negative results in the ELISA and in both pathological and cultural 
examinations. 
(Brocchi et al., 1993) reported monoclonal antibodies which 
recognized a 70 kDa protein from the PG1 strain of MmmSC but did not 
react with the type strains of other members of the M.mycoides cluster.  
Competitive ELISA using the monoclonal antibodies were more sensitive 
than the CFT for detecting antibodies in affected herds and were generally 
more specific when used in negative herds. 
A c-ELISA has been developed (Le Goff and Thiacourt, 1998) and 
validation tests have been performed in Africa (Thiacourt et al., 1999). This 
test uses a mouse monoclonal antibody IgG1 that recognizes an epitope 
localized on protein with an apparent molecular weight of 80 kDa. 
Availability of the test seems to be a problem. While this test has 
considerable advantages in term of ease of testing and standardization of 
results, the c-ELISA has sensitivity levels similar to the CFT. Clearly more 
sensitive techniques such as ELISA using better antigens enabling mass 
screening are necessary blocked by highly specific confirmatory tests such 
as immuno-blotting tests. 
A Tween 20 treated MmmSC cell fraction shows increased specificity 
in the indirect ELISA compared to conventional whole cell antigens whilst 
maintaining sensitivity (Ayling et al., 1999b). Tween 20 ELISA was 
compared to the CFT in an examination of 170 sera from Portuguese herds 
affected by CBPP; there was 88% agreement between the ELISA and IBT; 
81% agreement between the CFT and ELISA and 79% agreement between 
the CFT and the Immunoblotting test (IBT). Furthermore in a study with 88 
cattle with CBPP lesions, the ELISA detected antibodies in 92%, the IBT 
91% and the CFT only 82% (Ayling et al., 1999). 
 
1.7.5.6. Immunoblotting test (IBT): 
Immunoblotting tests (IBT) was described by (Goncalves et al., 1998) in 
which the simultaneous presence of five antigens (110, 98, 95, 62/60 and 48) 
was highly characteristic of sera from infected cattle.    
These tests were compared to the CFT in an examination of sera from 
Portuguese herds affected by CBPP (170 cattle). There was 79% agreement 
between CFT and IBT. In a study of 88 cattle with CBPP lesions IBT 
detected 80 and CFT detected 72 (Ayling et al., 1999b). 
(Abdo et al., 1998; 2000) identified a 48 kDa protein named LppQ which 
was found in the type strain and European, African and Australian field 
strains. They used the protein in immunoblotting test for the sero detection 
of MmmSC in experimentally infected cattle.  
 
1.7.6. Antigen detection systems: 
1.7.6.1. Monoclonal Antibody-Based Sandwich ELISA: 
Rodriguez et al., (1996) reported a monoclonal antibody-based sandwich 
ELISA that could detect as little as 10 over 5 cfu/ml of both Mmm biotypes 
within two hours. Sensitivity could be improved significantly by incubating 
samples for 48 hours. This test does not distinguish between M.mycoides SC 
and LC biotypes but coupled with pathological and serological information 
from affected animals the test could prove useful. 
 
1.7.6.2. Immuno Cyto-Chemistry (ICC):   
Immunocytochemistry (ICC) is increasingly used to confirm the 
diagnosis of CBPP particularly where the causative organism MmmSC is not 
recoverable (often following long transport distances) where animal has died 
of acute disease or where serology is not possible or unclear (Ferronha et al., 
1990; Scanziani et al., 1997). However the sensitivity of ICC using 
polyclonal serum can be low and non specific results frequently occur 
(Bashiruddin et al., 1999). 
 
1.7.7. Molecular diagnosis: 
1.7.7.1. Polymerase chain reaction (PCR): 
PCR is a rapid and sensitive diagnostic method. It allows detection of 
MmmSC directly in samples of lungs, bronchial lymph nodes, nasal swabs, 
pleural fluid and blood. Pre-incubation for 24hrs of clinical specimens in 
growth medium may increase test sensitivity (De Santis et al., 1997). If used 
for the identification of new isolates it reduces drastically the time required 
(24-48 hrs versus 2-3 weeks). The assay has been used as a diagnostic tool to 
detect MmmSC in the course of CBPP outbreaks that have affected Europe 
recently (Bashiruddin et al., 1994, 1999). However the traditional methods 
for isolation and identification of the causative agent of CBPP are time 
consuming leading to significant delay. To overcome this problem, both 
single and nested PCR systems have been developed for identification of 
MmmSC (Taylor et al., 1992; Bashiruddin et al., 1994, b, 1999a, b; Dedieu 
et al., 1994; Hotzel et al., 1996; Miserez et al., 1997). 
Primers based on the sequence of the so-called CAP gene of M.Capri 
amplify a 0.5 kb region of MmmSC, MmmLC and M. capri but do not 
amplify DNA from other members of the cluster. Identification is carried out 
by restriction fragment analysis of PCR product with ASNI (Bashiruddin et 
al., 1994b). 
Nested (two step) PCR has improved the sensitivity of detection. Both 
PCR reactions were highly specific to MmmSC. Two nested pairs of 
Oligonucleotide primers which were designed by evaluation of the most 
heterologous segments between the P72 gene of MmmSC and the closely 
related lipoprotein P67 gene of Mycoplasma subsp. bovine group 7 (PG50) 
were used (Miserez et al., 1997). 
Two PCR detection systems based on the 16S r-RNA genes have also been 
developed for identification of MmmSC with high sensitivity and specificity 
(Johansson et al., 1998; Persson et al., 1999). Both systems amplify the 
genes from all members of the M.mycoides cluster. In one of the systems, 
the final identification is performed by restriction enzyme analysis with AluI. 
The other system (PCR-Laser Induced Fluorescence, PCR-LIF) is based on a 
sequence length difference between the two 16S rRNA genes of MmmSC 
and the final identification is performed by fragment analysis of fluorescent 
labeled amplicons with a DNA sequencer. A comparatively large number of 
samples can also be handled by PCR-LIF (Persson et al., 1999). 
Colorimetric PCR has overcome the problem: specific ds-DNA 
produced by PCR is captured and detected enzymatically in a 96 well 
microtitre plate (Bashiruddin et al., 1999a). The results of colorimetric 
detection of PCR products correlate well with those obtained by gel 
electrophoresis, which reduces the analysis time by 50 % and allows the use 
of standard equipment available for ELISA serology. 
1.8. Disease Control and Eradication: 
The most effective method of eradication of such a chronic insidious 
disease by testing individual animals, slaughter of all reactors encountered 
with compensation of the owners (stamping out), vaccination of the non 
reactors by reliable immunizing product and practice of stringent monitoring 
methods. This can only be carried out at a very large initial expense 
(Abdulla, 1969). 
  
1.8.1. Stamping out: 
Clean countries prohibit importation of living animals from countries 
where the disease is endemic but if the disease is introduced in the country, 
eradication is based on stamping out policy (Hudson, 1971). This includes: 
Slaughtering of all clinical cases and contact cattle, restriction of cattle 
movement in and around infected area and payment of compensation for 
cattle owners. Stamping out policy is the method of choice where the 
infection is detected early, where the extension of outbreak is limited and 
where the staff and finance permit its vigorous execution. But in cases where 
infection has progressed till it involved large numbers of cattle stamping out 
is not suitable.  
 
1.8.2. Testing and Elimination of Reactors: 
This method depends on quarantine of the infected herd, the 
slaughtering of clinical cases, bleeding for CFT and simultaneous 
vaccination of all contact animals. As soon as CFT results are available, 
reactors are also slaughtered. The cattle in the surroundings should also be 
vaccinated. CFT should be repeated monthly accompanied by slaughtering 
of reactors till the herd was clear (Hudson, 1971). 
1.8.3. Vaccination: 
In countries where the disease is enzootic such as most of the African 
countries including the Sudan in which the mode of animal husbandry is 
nomadic and restriction of movement is difficult; Segregation, Quarantine of 
the infected herd, Testing and Removal of positive animals and Annual 
vaccination are the routine methods for the disease control (Karib, 1958, 
Hudson, 1971 and Abdulla, 1975). The disease is very difficult to eradicate 
under African conditions due to free movement of nomadic tribes. 
A joint campaign (JP28) against this disease was recommended by 
Directors of Veterinary Services in African countries at their meeting in 
Khartoum in 1973 (Abdulla, 1975). It was suggested to vaccinate cattle in 
East, West and Central African countries using T-1 strain of M. mycoides for 
three consecutive years or more.  
 
1.8.4. Chemotherapy: 
Although at the moment chemotherapy can not be used to eradicate 
CBPP, a number of drugs are available which can be used to influence the 
course of the disease in the individual animal. The first drug considered to 
be useful in specific treatment was Neosalvarsan; this was introduced early 
in the thirties by French workers in West Africa where it was reported to 
reduce losses in acute outbreaks of the disease. Turner (1961) investigated 
the invitro activity of some 40 preparations including antibiotics against M. 
mycoides and summarized earlier work on the subject. He found the 
organism relatively susceptible to a number of substances including 
Chloramphenicol, Streptomycin, Oxytetracycline, some Redox agents, some 
mercurials and Arsenicals, Nitrofurazone and Mepacrine. He confirmed its 
relative insusceptibility to Penicillin and found a number of other 
compounds including some Sulfonamides and Sulfones that might be added 
to the selective media to suppress the growth of contaminating bacteria. 
Hudson and Etheridge, (1965); Reported on the activity of the antibiotic 
Tylosin.  
The expert panel (FAO, 1967); unanimously opposed the 
chemotherapeutic treatment of actual cases of CBPP and strongly 
recommended “that mass drug or antibiotic treatment of CBPP should be 
discouraged because it increases the number of carriers. Chemotherapy to 
control vaccination reactions is not objectionable.” 
In spite of official condemnation, antibiotics are used so advice is 
necessary on which are the most effective. Ayling et al. (2000a) carried out 
an in vitro trial of the effects of five commonly used antibiotics on a number 
of strains of MmmSC, and concluded that tilmicosin and danafloxacin were 
effective both in terms of mycoplasmastatic and mycoplasmacidal activity; 
florfenicol and a tetracycline provide intermediate effectiveness while 
spectinomycin was ineffective against some strains. The use of 
fluoroquinalones, such as danafloxacin, is causing concern amongst 
regulatory authorities that feel these drugs should be restricted to human use 
because of rapid increases in microbial resistance. 
 
 
 
 
 
 
 
 
1.9. The disease in the Sudan: 
CBPP has been enzootic in the Sudan since the beginning of this 
century (Anon, 1912). It is considered one of the most serious diseases of 
cattle in the Sudan, leading to economical losses in forms of debilitation and 
death of sick animals and adversely affected foreign trade (Abdulla, 1975; 
Shallali, Elmahi, Yazeed and Abdalla, 1998). 
In the Sudan the disease was first observed in 1875 in Darfur Province 
and later spread to Khartoum Province where it caused great losses among 
cattle (Anon, 1925). The disease disappeared during the Mahdi wars in 
1889. In 1912 the disease reappeared again in Kordofan Province. The 
source of infection was from infected trade animals brought from West 
Africa (Anon, 1912). From there the disease spread quickly southwards and 
eastwards of the province. In 1913 the disease was reported in Nuba 
Mountains, the White Nile, Blue Nile, Upper Nile and Bahr El Gazal 
provinces. In 1914 the disease reached Khartoum Province and then spread 
to Kassala Province in 1917 and Barber Province in 1923 (Anon, 1925). 
Presently, the disease is enzootic in the Western, Southern and Central 
Provinces of the country. Rare or almost no outbreaks were reported from 
Eastern and Northern Provinces and this may be due to the sedentary 
animals movement and limited animal numbers in these provinces (Anon, 
1969). 
  
 
 
 
 
 
CHAPTER TWO 
GENERAL MATERIALS AND METHODS 
 
2.1. Study Area: 
This study was carried out in the Southern Sudan, in Unity State. 
Southern Sudan has an area of approximately 650,000 square km, bordered 
by Central African Republic, Chad, Democratic Republic of Congo, Uganda, 
Kenya, and Ethiopia. It is divided into several ecological zones; rainforest, 
savannah forest, flood plains, swamp and semi desert. 
Unity State or El Wihda was re named during the early 1990 in a new 
administrative re division of Sudan. Unity state was divided into four 
localities; Rubkona, Meom, Pariang and Ler localities. Unity state is 
surrounded by Southern Kordofan, Western Kordofan, Jonglei, Warab, 
Northern Bahr Algazal, Lakes and Upper Nile States. 
The State former name was Western Upper Nile State. Western Upper Nile 
State is located in the center of Southern Sudan. Most of the Unity State 
lands were described as low swampy lands covered with remaining water 
from the rainy season during most of the year. It was known as a Sudd land 
as well. The region is about 320 km (about 200 mi) long and about 360 km 
(about 220 mi) wide. It is fed by major tributaries of the north flowing White 
Nile, including the Bahr al ‘Arab’. Just north of Bor, the White Nile 
overflows onto a broad clay plain. Because the gradient of the land is so low, 
the rivers waters spread to form many swamps and lagoons. Papyrus and 
floating water plants, known in Arabic As-Sudd, grow densely in the region. 
The river is no longer navigable in As Sudd, as half of its water evaporates 
in the slow-moving waterways. The Dinka and Nuer peoples live in the 
grassy plains between the watercourses. Since about the 10th century, these 
pastoral people have raised herds of cattle, sheep, and goats for their 
livelihoods. The ethnic groups of the State are mainly Nuer, Baggara and 
Dinka. The Nuer are divided into twelve sub-tribes or clans; Jikany, Leek, 
Bul, Jagei, Dok, Nyuong, Dor, Dinka (Pariang), Ghol, Lak, Thiang and 
Gawier. Each sub-tribe is originated and based in part of the Greater Upper 
Nile Area. In Unity State the Western Nuer sub tribes are the dominant. It is 
more often to find the Jikany, Leek, Bul, Jagei, Dinka (Pariang) and Dok sub 
tribes in the study area. There is also a part of the Dinka tribe in Pariang 
locality but considered as a part of the Nuer tribe. Some of the Western 
Sudan Arab or Misserya nomadic tribes (Baggara) are seasonally occupying 
the Northern parts of the state for the water and grazing during the dry 
season up to the beginning of the subsequent rainy season then they drive 
back to Western and Southern Kordofan states. (Figure. No.1)  
 
 
 
 
 
 
 
 
Figure. No.1. Major Ethnic Groups and Cattle Movement Paths in 
Unity State. 
2.2. Clinical Data: 
Clinical data obtained from the reports of WN-POC\CD veterinary 
clinics. The clinical data was entered and analyzed by using the Statistical 
Package for Social Studies (SPSS) software. 
Descriptive data, Cross tabulation and Graphs were acquired through the 
SPSS software as well.  
  
2.3. Samples for Bacteriological and Serological Examinations: 
Tissue and serum samples were collected from different herds and 
locations in Unity State.  
Tissue samples: Eight lung tissue samples were collected from Rubkona 
locality (Rubkona and Bentiue).   
Serum samples: Total of 600 serum samples were collected from the four 
localities of Unity State (Rubkona, Meom, Pariang and Ler localities). 
All serum samples were collected from cattle throughout different seasons of 
the years 2003 and 2004.  
The lung tissues samples were cultured to isolate the Mmm organism, while 
the serum samples were examined serologically for the presence of the 
antibody of MmmSC by both CFT (443) and C-ELISA (320) tests in the 
Central Veterinary Research Laboratory-Soba (CVRL). 
 
2.3.1. Tissue samples: 
The eight lung tissue samples were collected from suspected lungs 
with sequestration during post mortem examination, small portion (piece) of 
lung was taken by sterile forceps, placed in sterile plastic bag, labeled and 
then stored frozen at -20° C before shipping via air in ice containers to the  
Central Veterinary Research Laboratory (CVRL-Soba). 
2.3.2. Serum samples: 
The six hundred bovine sera were collected during this study 
according to the following procedure:- 
Ten ml of blood were colleted aseptically from the jugular vein of life 
animals by vein-puncture using sterile needles then drown into sterile plain 
vacutainers. The blood was left to stand at ambient temperature until the clot 
formed then the clot was removed with sterile rods, the sera were left at 
room temperature overnight were transferred to sterile Eppindroff tubes, the 
samples were labeled with animal number, date, location, sex, and age and 
vaccination status. Sterile syringes were also used to collect part of the 
samples. The serum containers were placed in a refrigerator at - 20 C° then 
shipped later in ice boxes to (CVRL).  
 
2.3.2.1. Serum sample  data: 
 
2.3.2.1.1.  Location of Samples: 
The tested sera were collected from different locations in Unity State 
according to the accessibility and security of the cattle herds as follow:- 
Rubkona: 36.6%, Thoan: 24.6%, Kilo-15, Kilo-30 and Mala: 25.1%, Gamos 
and Mirmir: 5.4%, Munga and Abyamnam: 8.3%. (Table No. 1.). 
 
2.3.2.1.2.  Sex of Sampled Animals: 
         91% (403) of the samples were collected from the females, while 9% 
(40) were collected from the males. 
 
 
 
Table No. 1. The Frequencies and Percentages of the Collected Serum 
Samples from different Locations in Unity State. 
 
 
 
Location Frequency Percent 
Rubkona 162 36.6% 
Thoan 109 24.6% 
Mala 111 25.1% 
Mirmir and Gamos 24 5.4% 
Munga and Abymnam 37 8.3% 
Total 443 100% 
 
 
 
 
 
 
 
 
 
 
 
2.3.2.1.3.  Breeds of Sampled Cattle: 
91.9% (407) of the samples were collected from the Nilotic cattle 
breed while 8.1% (36) from the Baggara cattle breed. 
 
2.3.2.1.4.  Season of Sample collection: 
30.5% (135) of the samples collected during the dry season 
(December, January, February, March, April) while 69.5% (308) collected 
during the rainy season (May, June, July, August, September, October, 
November). 
 
2.3.2.1.5.  Vaccination Status of Samples: 
87.8% (389) of the collected samples never been vaccinated before while 
12.2% (54) practiced vaccination at least once before. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4. Culture media: 
Both liquid and solid Medium used for culturing the samples. 
 
2.4.1. Liquid media: 
2.4.1.1. Gourlay’s medium (Gourlay, 1964): 
The medium consists of the following ingredients:- 
   Bacto-tryptose (DIFCO)                                     2.00 gm 
   Dextrose                                                              0.50 gm 
   Sodium Chloride                                                 0.50 gm 
   Di-sodium hydrogen phosphate (Anhydrous)     0.25 gm 
   Glycerol                                                               5.00 gm 
   Yeast Extract (DIFCO)                                        0.10 gm 
   Distilled water                                                     100    ml 
All these ingredients are dissolved by steaming. After cooling, 10 ml of 
inactivated horse serum, 100 I.U of penicillin and 1.0 ml thallium acetate 
(10% w/v) were added to each 100 ml of the broth medium. The pH was 
adjusted to 7.6 and the medium was sterilized by Seitz filter (ESK, 14D) 
under negative pressure (Gourlay, 1964).  
 
2.4.1.2. Brain Heart Infusion Broth (Difco): 
The medium consists of the following ingredients: 
Heart infusion broth (25g), yeast extract (5g), D.N.A (5g) and 1000 distilled 
water. The pH was adjusted to 7.6 after dissolving the mentioned 
ingredients. After that fresh yeast extract (100ml), horse serum (200ml), 
penicillin (200.000 IU) and 10% Thallium acetate solution (1ml) were 
added. The medium was prepared according to the manufacturer instruction.   
 
2.4.1.3. Brucella Broth (Difco):  
This media consisted of Brucella broth (Difco) (28g), yeast extract 
(1g) and 1ml glycerol. The pH was adjusted to 7.6, and then 200 ml horse 
serum, penicillin (100.000 I.U) and 0.3 ml thallium acetate were added. 
The medium was prepared according to the manufacturer instruction. 
 
2.4.2. Solid media: 
 
2.4.2.1. Gourlay’s Agar Medium: 
Agar (1.5% w/v) was added to Gourlay’s broth medium mentioned in 
(2.4.1.1.). 
 
2.4.2.2. Brain Heart Infusion Agar: 
Agar was added to the brain heart infusion broth mentioned in 
(2.4.1.2.). 
 
2.4.2.3. Brucella Agar Medium (Oxoid): 
It consisted of Brucella Agar (Oxoid) (43g), yeast extract (1g), 
glycerol (10 ml) and 1000 ml distilled water. Then the pH was adjusted to 
7.6 and sterilized by autoclaving (15 lbs/square inch for 15 minutes) and 
then 100 ml horse serum, 20 ml fresh yeast extract, 0.33 ml penicillin and 
0.25 ml thallium acetete10% were added.      
 
2.4.3. Basic Cultivation Technique for Mycoplasma: 
Cultivation was done by inoculation of the specimen either directly 
into liquid media and subsequent transfer to agar media, or by culturing of 
the specimen directly into agar media.  
2.5. Buffers: 
There were different types of buffers used in both CFT and C-ELISA 
tests. 
2.5.1. Veronal Buffer:  
This buffer was used to dilute the reagents used in the complement 
fixation test. It consists of the following ingredients:- 
    Sodium chloride:                                   83.8    gm 
    Sodium bicarbonate:                               2.52 gm  
    Sodium 5-5 diethylebarbiturate:              3.0   gm 
    5-5 Di-Ethyl Barbituric acid:                  4.6   gm       
    Magnesium chloride:                               1.0   gm 
    Calcium chloride:                                    0.2   gm 
    Distilled water:                                   1000      ml 
    PH:                                                           7.4 
 
2.5.2. CFT-diluent tablets (Oxoid): 
One tablet dissolved in 100 ml worm distilled water and the pH was 
adjusted to 7.4. It is used for dilution of different reagents in CFT. 
 
2.5.3. Coating Buffers: 
This was used for the dilution of Mycoplasma antigen and it consists of 
the following ingredients: 
Sodium hydrogen carbonate:           2.93 gm  
Sodium carbonate:                           1.59 gm 
Sodium aside:                                  0.20 gm 
Distilled water:                                1000 ml 
The pH was adjusted to (9.6) 
2.5.4. Phosphate Buffer Saline (PBS): 
It consists of the following ingredients: 
Di-sodium hydrogen orthophosphate:         1.4 gm 
Sodium Chloride:                                        7.0 gm 
Potassium chloride:                                     0.2 gm 
Potassium hydrogen phosphate:                  0.2 gm 
Distilled water:                                         1000 gm 
The pH was adjusted to 7.4 
 
2.5.5. Diluting Buffer:   
This buffer was used to dilute the sera samples and the conjugate. It 
consists of the following ingredients: 
Phosphate buffer saline (PBS):         1.0 Liter 
Tween 20:                                          0.5 ml 
The ρH was adjusted to 7.4 and stored at 4C°. This buffer should be used 
within three weeks from the date of preparation. 
 
2.5.6. Substrate Buffer: 
It consists of the following ingredients: 
Citric acid tri sodium dehydrate:           17.34 gm 
Citric acid:                                               7.84 gm 
Distilled water:                                        1.0    Liter 
The pH was adjusted to 4.5-5.5 and it was used to dilute the ODP. 
  
2.5.7. Washing Buffer: 
This was used to wash the ELISA plates. It was kept at room temperature 
and used within one week. It consists of the following ingredients: 
Sodium chloride:                    45.0 gm 
Tween 20:                                 2.5 gm 
Distilled water:                      1000 Liter 
 
2.6. Solutions: 
2.6.1. Alsever’s Solution: 
This solution was used for the preservation of sheep red blood cells. It 
consisted of: 
Sodium citrate:                  12.0 gm 
Sodium chloride:                 4.2 gm 
D-glucose anhydrous:        20.5 gm   
Distilled water:                    1.0 Liter 
 
2.7. Reagents: 
 
2.7.1. Antigens: 
One type of antigens was prepared and been used for the CF test. 
 
2.7.1.1. Whole Mycoplasma Cell Antigen: 
This was prepared by inoculating two liters of serum broth medium 
with 100 ml of a 48 hours culture of M. mycoides and incubated for 14 days 
aerobically at 37C°. After checking for purity then culture was centrifuged at 
12000 rpm. The sediment was then washed three times by suspending in 
phosphate buffer saline (PBS) and centrifuged at 3000 rpm. The antigen 
produced was finally suspended in PBS at 100 concentrations (Al-Aubaidi 
and Fabricant, 1971) and distributed in small aliquots of approximately 1 ml 
and stored at 4° C. 
2.7.2. Test sera: 
Blood samples (10 ml each) were drowning aseptically from the 
jugular vein. Serum was separated by stand overnight in Refrigerator (4C°) 
and kept at -20C° till used. 
 
2.7.3. Preparation of Blood Cell: 
Fifty ml (50 ml) of sheep blood were collected aseptically in bottle 
containing 50 ml of Alsever’s solution and kept in the refrigerator overnight. 
10 ml of defibrinated blood suspension were centrifuged at 3000 rpm. The 
RBCs given were washed three times in the buffer before being suspended 
in Veronal buffer in a concentration of 2% RBCs. 
 
2.8. Biochemical Tests: 
2.8.1. Digitonin Sensitivity Test: 
The sensitivity to digitonin indicates the requirement for sterol; 
members of the genus Mycoplasma are digitonin sensitive, and this test is 
performed after the initial isolation of suspicious mycoplasmas. 
 
2.8.2. Growth Inhibition Test: 
This test carried out on agar media with specific antiserum. The test is 
relatively specific; it can identify the two subspecies of M. mycoides but 
cannot distinguish between SC and LC. 
 
2.9. Serological tests: 
Complement Fixation Test (CFT) and Competitive Enzyme Linked 
Immuno Sorbant Assay (c-ELISA) were prepared and performed on serum 
samples. 
2.9.1. Lindley Plate Complement Fixation Test (CFT): 
Lindley Plate Complement Fixation Test (Lindley, 1960) 
The preparation of the heamolytic system, titration of the antigen and 
complement and the dilution of the tested sera were carried out according to 
Lindley (1960). The haemolytic system was prepared by the addition of 2% 
sheep red blood cells suspension with equal volume of the titrated 
haemolysin dilution and placed at 37° C for half an hour. 1/10 dilution of the 
tested sera were done and placed in 56° C water-bath for ½ an hour for 
inactivation of the complement. Complement, antigen dilutions and the 
sequence of the test were carried out according to Lindley (1960). The plates 
were either read immediately or left in the refrigerator overnight.  
The essential difference between this test and Campbell and Turner test was 
that; instead of using series dilutions of serum against a fixed amount of 
complement, serial dilutions of complement were used with constant One-
In-Ten (1\10) dilution of inactivated serum. Results were expressed not as 
serum titer but as the amount of complement fixed. 
The end point was the dilution of complement giving 50% haemolysis and to 
facilitate reading haemolytic standards were prepared to indicate 0, 25, 50, 
75 and 100% haemolysis respectively. The test was conveniently made by 
using Micro Plates (instead of Perspex blocks 7 x 5 ¾ x 5/8 in deep, drilled 
to have 80% cups, 8 per row and 10 per column). 
This method has proved satisfactory when the number of sera to be tested 
does not exceed 100. When larger numbers were involved the Haddart 
technique is more suitable. The reagents can be prepared by the techniques 
already given or it may be more convenient to purchase them. All dilutions 
were made with the buffer diluent used in the Campbell and Turner test were 
prepared either from the formula given or from tablets.  Among the various 
commercial sources of complement (C´), freeze-dried negative serum, 
haemolytic amboceptor and preserved sheep red cells were obtained from 
Burroughs Wellcome and Co. The buffer tablets diluents obtained from 
Oxoid Ltd.   
  
2.9.1.1. Materials:- 
 
2.9.1.1.1. Titration of the Complement: 
A preliminary titration of the C´ is necessary only when a new batch 
was being introduced. The minimum haemolytic dose (M.H.D.) was defined 
as the smallest amount that will cause 50% percent suspension of sheep red 
cells sensitized with the optimal amount of haemolysin.  
C´ with a titer of less than 1/100 was not used for the test.  
The range and intervals of the C´ serial dilution were important. It has been 
found that a series with 0.1761 logarithmic intervals (i.e. one made by 
carrying over 2 milliliters to 1 milliliter of the diluent) was suitable. The 
final (eighth) tube contained only buffer. There were therefore only seven 
tubes in the series 1/10, 1/15, 1/22, 1/33, 1/50, 1/75 and 1/116. In doubling 
dilution (with 0.3010 logarithmic intervals) the steps were too great; such a 
series did not differentiate sufficiently between sera. 
 
2.9.1.1.2. Sheep Red Blood Cell Suspension: 
Cells were collected in modified Alsever’s solution as described under 
Campbell and Turner test. They were washed as described under the 
Campbell and turner test; but a final suspension of 2% percent instead of 6 
percent was prepared. 
 
2.9.1.1.3. Haemolytic Amboceptor: 
This is usually obtained commercially. With each new batch a 
titration (1/50 to 1/3200) against the C´ dilutions used in the test have been 
made to determine the minimum haemolytic dose which caused 50% percent 
haemolysis in the presence of 4 M.H.D. of C´. In the test three times this 
dose was used. 
 
2.9.1.1.4. Sensitization of Red Blood Cells: 
One volume of washed red cells (2% suspension) and one volume of 
haemolytic amboceptor containing 3 M.H.D. of haemolysin were mixed 
together rapidly and then placed in the incubator at 37 C° for 30 minutes 
after which they were stored in the refrigerator until required.  
 
2.9.1.1.5. Negative Bovine Serum: 
Unheated negative bovine serum was usually added to the antigen as 
described below since it enables the test to provide more consistent results. 
 
2.9.1.1.6. Antigen: 
The dilution of antigen used was that recommended for the Campbell 
and Turner test by the issuing laboratory. In making the dilution one part of 
negative bovine serum was added to give a final dilution of 1/160 in the 
diluted antigen. 
 
2.9.1.1.7. Cleansing of Micro Plates: 
The plates were not cleaned with abrasives. They were washed 
immediately after use in tap water and then immersed in 0.5% NaOH 
overnight. After rinsing in tap water they were soaked in 0.5% HCL and 
when this has been rinsed of they were washed in distilled water. After 
drying in a dust-free atmosphere they were stored inverted in a clean 
cupboard or drawer. 
 
2.9.1.1.8. Measurement of Volumes: 
Chemically clean dropping-pipettes delivering 0.02 milliliters were used. 
They could be made of glass tubing, calibrating and standardized in the 
laboratory.     
 
2.9.1.2. Method: 
A known positive serum, a known negative serum, a C´ titration (a 
row of cups containing the C´ dilutions but no serum or antigen) and a set of 
haemolysis standards were included in each test. 
An estimate was made for the volume of reagents required to test the number 
of samples of serum to be examined. Each serum required 2 drops of each C´ 
dilution, 8 drops of antigen dilution and 32 drops of sensitized red cell 
suspension if a complete row of an anti-complementary control was included 
(as in the confirmatory test for positive sera). 
The 1/10 dilutions of the sera to be tested were set up and inactivated at 56 
C° for 30 minutes. The 2% red cell suspension and haemolysin dilution were 
prepared and mixed before placing in the incubator for half an hour (30 
minutes). The antigen dilution was also made and the C´ dilutions were 
prepared and placed in the refrigerator or on ice.  
All the reagents were been ready before the test started and the work was 
carried out quickly on every occasion. 
One drop of 1/10 inactivated serum was placed into each cup using one row 
of 8 cups for each unknown serum. In a confirmatory test for a positive 
serum two rows would be necessary, the second for the anti-complementary 
control. 
The C´ was added as follow:  
Starting with 8th column, one drop of the diluent was placed in the last cup 
of each row, working down the column of as many plates as were necessary 
to complete the test. Then the test proceeded with dropping the most dilute 
C´ into the cups of the 7th column the next dilution into the cups of the 6th 
column and so on. 
Next antigen was added, one drop per cup (except in the confirmatory test 
on positive sera when antigen omitted from the cups of the second row of 
each such serum; instead of antigen a drop of diluent was added to each cup 
in these rows). 
An antigen control was included when a new batch of antigen was 
introduced to ensure that the antigen was free from anti-complementary 
activity. This consisted of a row of cups containing the antigen and the C´ 
dilutions but no serum dilutions were added. The serum dilution in each cup 
was replaced by a drop of diluent.  
Finally one row for the complement controls was allowed. These cups 
contained the dilutions of C´ but no serum or antigen and therefore required 
two drops of diluent to complete the volumes. 
The plates were rotated gently to mix the contents of the cups and inserted 
them in a humidified container in the incubator at 37° C for 30 minutes. To 
each cup we added 2 drops of sensitized cells and after mixing replaced for 
30 minutes in the incubator. Then Removed and read. Reading might be 
easier if the plates were left in the refrigerator until all the Un-haemolyzed 
cells have settled.    
Results were recorded according to the amount of C´ fixed by the 1/10 
dilutions of sera. The end point was taken as the dilution of C´ in which 50% 
percent haemolysis had occurred. The degree of positive was indicated by 
the difference between the end points in the row with antigen and the row 
without. Pro- and anti-complementary samples were infrequent.     
      
2.9.2. Competitive-Enzyme-Linked Immuno- Sorbant Assay: 
CBPP Serum Competition ELISA-Version P05410/01 kit which has 
been used was produced by CIRAD-EMVT, Montpellier, France by 
developing a Competition ELISA (c-ELISA) based on Monoclonal Anti-
MmmSC antibody (named 117/5). This test is an alternative to the CFT for 
the OIE and can be used for the official CBPP controls. 
A competitive ELISA developed at CIRAD-EMVT, Montpellier, may have 
advantages in terms of ease of testing and standardization of results, but it 
has sensitivity levels similar to CFT and thus will enable the persistence of 
disease as seen with CFT (Le Goff and Thiaucourt, 1998).  
 
2.9.2.1.  Materials: 
CBPP Serum Competition ELISA kit, Version P05410/01 from 
CIRAD-EMVT/ Institute POUQUIER, FRANCE. 
 
2.9.2.1.1. Contents: 
Monowell coated micro plates, Wash concentrate (20x), Dilution 
buffer (24), Controls: Strong positive control (CP++), Weak positive control 
(CP+) and Negative control (CN), Monoclonal antibody 117/5 (anti-
MmmSC)-(Mab)-(Freeze-dried), Monoclonal anti-mouse IgG peroxidase 
conjugate, Revelation solution (3)-(TMB) ready to use and Stop solution 
(H2S04 0.5M solution).  
 
2.9.2.1.2.  Equipment:  
ELISA reader, Centrifuge, Centrifuge tubes and micro tubes, Vortex 
or similar, Micro plate washing system that distribute 300 microleter per 
well, Tray (Boat shape), Precision Micropipettes and Multi-dispensing 
micropipettes, Disposable pipette tips, Distilled water, Pre-plates for pre-
dilutions, Micro plate covers (lid, aluminum foil or adhesive), Incubator at 
+37° C (+ 3° C), Plate Agitator and Printer. 
 
2.9.2.2. Method: 
The wells of the polystyrene microtiter plates were coated with an 
MmmSC lysate. Serum samples to be tested were diluted and incubated with 
the specific monoclonal antibody (117/5) in a pre-plate. This mixture was 
then transferred into the MmmSC coated micro plate. Any antibody specific 
to MmmSC in the serum will form an MmmSC / bovine antibody immune 
complex, which effectively masks the MmmSC sites. In this case the 
monoclonal antibody cannot bind to the corresponding epitope. 
After washing, an anti-mouse-IgG antibody coupled to peroxidase was 
incubated in the wells. In the presence of specific MmmSC antibodies in the 
serum that is being analyzed, the monoclonal antibody (117/5) is not fixed in 
the plate and the conjugate cannot bind in the wells. On the contrary, the 
conjugate can bind to the monoclonal antibody. 
After washing, the enzyme substrate (TMB) was added to the conjugate, 
forming a blue compound becoming yellow after blocking. The intensity of 
the color is an inverse measure of the proportion of anti-MmmSC antibodies 
in the serum sample tested. 
The cut-off was calculated by using the results obtained from a monoclonal 
control (Cm) and a conjugate control (Cc). The positive and negative 
controls were delivered with the kit. They were added to each micro plate 
and the results were validated. 
 
2.10. Participatory Epidemiology: 
Participatory Epidemiology is an emerging field based on the use of 
participatory techniques for the harvesting of qualitative epidemiological 
intelligence contained within community observations, existing veterinary 
knowledge and traditional oral history. It relies on the widely accepted 
techniques of participatory rural appraisal, ethno veterinary surveys and 
qualitative epidemiology (Schwabe, 1984). This information can be used to 
design better animal health projects and delivery systems, more successful 
surveillance and control strategies or as new perspectives for innovative 
research hypotheses in ecological epidemiology. 
  
2.10.1. Direct Observations: 
The system of the community life in the villages and pastoral camps 
were observed while walking and talking to the different community 
members. 
The observational walker is definitely worth the trouble, Narayan (1996) 
refers to those as ‘walking surveys’.   
 
 
 
2.10.2. Interviews: 
Interviews with the local livestock owners, Chiefs (Salateen and 
Princes) and Veterinarians were conducted so as to asses and cross check the 
livestock situation, problems, major cattle diseases, disease outbreaks, 
migration routes and other useful information. 
The local name of the disease and the on set occasions were determined by 
the respondents. 
 
2.10.3. Mapping: 
The participants (Respondents and the Informant) were asked to 
sketch a map of useful resources, grazing movement, trade movements, 
community boundaries and origin.  
 
2.10.4. Seasonal Calendar: 
The informants were asked to verify their animal health problems 
according to the season and the climatic changes. 
 
2.10.5. Ranking, Scoring and proportional Piling: 
The informants were asked to construct a list of the animal health 
diseases for particular species in the area then the informants were asked to 
determine the most important diseases and rank those diseases list wise 
according to the importance, season, locations and prevalence. 
The informants were asked to score the ranked diseases in 2.10.4 above by 
using simple scoring and proportional piling.  
 
 
 
2.11. Secondary Data: 
The records of Animal Resources and Fisheries Director were revised 
so as to collect useful information about CBPP in Unity State. The director 
of ARF conducted vaccination campaigns during the early 1990s in Bentiu 
and Northern parts of the state and did not reach cattle camps towards the 
south due to the insecurity struggles; the records did not mention any 
vaccination coverage against CBPP in particular due to the vaccine quality 
(Lyophilized), where there was No mean to keep the vaccine frozen until 
use.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER THREE 
RESULTS 
 
3.1. Clinical Data: 
The analysis of the clinical data showed that there were six highly 
infectious diseases among cattle in Unity State: Pneumonia (Respiratory 
infections), FMD, H.S, Brucellosis, CBPP and B.Q. (Figure No.2.). 
The prevalence rates of those diseases were demonstrated in (Figure No. 3.).  
The percentages of the infectious cattle diseases were as follow: 
Pneumonia: 41.5%, FMD: 28%, H.S: 13.8%, Brucellosis: 11.5%, CBPP: 
4.8% and B.Q: 0.5%. (Figure No. 4.). 
  
3.2.  Sample Collection Year: 
Twenty four point six (24.6%) out of the total numbers of samples 
were collected during 2003, while 75.4% of samples were collected during 
2004 due to moderate improvement of security situation. (Figure No. 9.)  
 
3.3. Isolation of the Agent: 
3.3.1. Culture of the Samples:- 
Eight lung tissue samples were examined by cultivation in different 
Mycoplasma Broth and Agar Medium (Gourlay’s, Brain heart infusion and 
Brucella). Two of them showed turbidity in the liquid media, later a 
noticeable growth and fried egg shape colonies have been clearly recognized 
after 7 days in the solid media.  
While the two isolates were under re culturing both of them were lost due to 
the poor conditions in the lab at that time and the isolates were never been 
re-isolated successfully again from the same culture. 
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Figure No. 2. Bar Chart demonstrates the Highly Infectious Cattle 
Diseases in Unity State as obtained from the Clinical Data. 
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Figure No. 3. Bar Chart demonstrating the Highly Infectious Cattle 
Diseases in Different Seasons as obtained from the Clinical Data. 
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Figure No. 4. Pie Chart demonstrating the Highly Infectious Cattle 
Diseases Percentages as obtained from the Clinical Data. 
 
 
 
 
 
 
 
3.4. Identification of the Agent: 
3.4.1. Biochemical Tests: 
3.4.1.1. Digitonin Test: 
After the first isolation, the culture showed sensitivity to Digitonin 
and that indicated the requirement of Sterol. Genus Mycoplasma members 
are Digitonin sensitive. 
 
3.5. Serological Tests: 
 
3.5.1. Growth Inhibition Test: 
The G.I test showed positive reactions. 
 
3.5.2. Complement Fixation Test: 
443 serum samples were tested using CFT out of the 600 been 
collected during the recent study.  
  
3.5.1.1. CFT Results: 
Twenty six percent (26%) of the tested samples with the complement 
fixation test showed positive reactions, 6.5% showed doubtful reactions and 
67.5% showed negative reactions. 
 
3.5.1.2. Sample collection year vs. CFT Result Cross tab: 
Eleven point three percent (11.3%) is the positive results showed by 
the CFT during 2003 while the CFT positive results increased to 14.7% 
during 2004. (Table No. 2.). Pearson Chi-Square test showed a significant 
relationship, the value was (0.000). 
 
  
 
Figure No. 5.  Complement Fixation Test on Micro plate.  
 
 
 
 
 
 
 
 
 
 
Table No. 2. Sample Collection Year vs. CFT Result Cross Tabulation: 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crosstab
50 50 9 109
11.3% 11.3% 2.0% 24.6%
65 249 20 334
14.7% 56.2% 4.5% 75.4%
115 299 29 443
26.0% 67.5% 6.5% 100.0%
 
 
 
 
 
 
2003     
2004 
 
Sample collection 
year 
Total 
Positive Negative Doubtful 
CFT-Result
Total 
3.5.1.3. Location vs. CFT Result Cross tab: 
 Positive results in Rubkona: 9.3%, Thoan: 11.3%, K15, K30 and Mala: 
3.1%, Gamos and Mirmir: 1.3% and Munga and Abyamnam: 1%. 
Negative results in Rubkona: 23.7%, Thoan: 11.3%, K15, K30 and Mala: 
21.3%, Gamos and Mirmir: 1.3% and Munga and Abyamnam: 7.2%. 
Doubtful results in Rubkona: 3.6%, Thoan: 2%, K15, K30 and Mala: 
0.9%, Gamos and Mirmir: 4.1% and Munga and Abyamnam: 0%. 
(Table No. 3.). Pearson Chi-Square test showed a significant relationship, 
the value was (0.000). 
 
3.5.1.4. Sex vs. CFT Result Cross tab: 
3.2% of the male samples showed positive reactions by the CFT while 
22.8% of the female samples showed positive reactions by the CFT. 
(Table No. 4.). Pearson Chi-Square test showed NO significant relationship, 
the value was (0.266). 
 
3.5.1.5. Breed vs. CFT Result Cross tab: 
In the Nilotic cattle breed 25.1% showed positive reactions by the 
CFT while in the Baggara cattle breed 0.9% showed positive reaction by the 
CFT. (Table No. 5.). Chi-Square showed moderate significant, (0.014). 
 
3.5.1.6. Season vs. CFT Result Cross tab: 
4.7% positive reactions exhibited during the dry season which 
increased to 21.2% during the rainy season by the CFT (Seasonal Pattern). 
(Table No. 6). Pearson Chi-Square showed a highly significant relationship, 
value was (0.000). 
 
Table No. 3. Locations of Samples vs. CFT Result Cross Tabulation: 
 
 
 
Location of Samples vs. CFT Crosstabulation
41 105 16 162
9.3% 23.7% 3.6% 36.6%
50 50 9 109
11.3% 11.3% 2.0% 24.6%
14 94 3 115
3.1% 21.2% .9% 25.3%
6 18 24
1.3% 4.1% 5.4%
4 32 36
1.0% 7.2% 8.2%
115 299 29 443
26.0% 67.5% 6.5% 100.0%
*
*
*
*
*
*
Rubkona
Thoan
Kilo 15, Kilo 30 & Mala
Gamos & Mirmir
Munga & Abyamnam
Location of Sample
Total
Positive Negative Doubtful
CFT-Result
Total
 
 
* Indicates Percentages  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 4. Sex of Sampled Animal vs. CFT Result Cross Tabulation. 
 
 
 
 
 
* Indicates Percentages  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crosstabulation
14 25 1 40 
3.2% 5.6% .2% 9.0%
101 274 28 403 
22.8% 61.9% 6.3% 91.0%
115 299 29 443 
26.0% 67.5% 6.5% 100.0%
* 
* 
* 
Male 
Femal 
Sex of Animal 
Total 
Positive Negative Doubtful
CFT-Result
Total 
Table No. 5. Types of Cattle Breed vs. CFT Result Cross Tabulation.  
 
 
 
Crosstab
111 267 29 407
25.1% 60.3% 6.5% 91.9%
4 32          0 36
.9% 7.2%          0% 8.1%
115 299 29 443
26.0% 67.5% 6.5% 100.0%
*
*
*
Nilotic
Baggara
Breed
Total
Positive Negative Doubtful
CFT-Result
Total
 
 
 
*Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 6. Season vs. CFT Result Cross Tabulation: 
 
 
 
 
 
* Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Crosstab
21 112 2 135
4.7% 25.3% .5% 30.5%
94 187 27 308
21.2% 42.2% 6.1% 69.5%
115 299 29 443
26.0% 67.5% 6.5% 100.0%
 
*
 
*
 
*
Dry season 
Rainy season
Season of the sample 
collection
Total 
Positive Negative Doubtful 
CFT-Result
Total
3.5.1.7. Vaccination vs. CFT Result Cross Tabulation: 
Two point nine percent (2.9%) of the CFT positive samples appeared 
in the vaccinated cattle while increased to 23% CFT positive samples in the 
Non-vaccinated cattle. (Table No. 7.). Pearson Chi-Square test showed NO 
significant relationship, the value was (0.592). 
 
3.5.2. Competitive Enzyme Linked Immuno Sorbant Assay:  
 
3.5.2.1. c-ELISA Results: 
Sixteen point six percent (16.6%) of the samples tested by the c-
ELISA test showed positive reactions, 12.5% showed doubtful reactions and 
70.9% showed negative reactions. 
 
3.5.2.2. Sample collection Year vs. c-ELISA Result Cross tab: 
Three point four (3.4%) is the positive results showed by the c-ELISA 
during 2003 while the c-ELISA positive results increased to 13.1% during 
2004. (Table No. 8.). Pearson Chi-Square test showed a highly significant 
relationship, the value was (0.000). 
 
3.5.2.3. Location of samples vs. c-ELISA Result Cross tab: 
Positive results in Rubkona: 0.3%, Thoan: 13.1%, K15, K30 and 
Mala: 2.5%, Gamos and Mirmir: 0% and Munga and Abyamnam: 0.6%. 
Negative results in Rubkona: 15.3%, Thoan: 18.6%, K15, K30 and Mala: 
27.5%, Gamos and Mirmir: 2.1% and Munga and Abyamnam: 7.1%. 
Doubtful results in Rubkona: 4.4%, Thoan: 0.6%, K15, K30 and Mala: 
3.4%, Gamos and Mirmir: 1.6% and Munga and Abyamnam: 2.5%.  
(Table No. 9.). Pearson Chi-Square test showed a highly significant 
relationship, the value was (0.000). 
 
3.5.2.4. Sex vs. c-ELISA Result Cross tab: 
Two point eight percent (2.8%) of the male samples showed positive 
reactions by the c-ELISA and 13.7% of the female samples showed positive 
reactions by the c- ELISA. (Table No. 10.). Pearson Chi-Square test showed 
NO significant relationship, the value was (0.120). 
 
3.5.2.5. Breed vs. c-ELISA Result Cross tab : 
In the Nilotic cattle breed 15.9% showed positive reactions by the  
c-ELISA while the Baggara cattle breed showed 0.6% positive reaction by 
the c-ELISA. (Table No. 11.). Pearson Chi-Square test showed a highly 
significant relationship, the value was (0.001). 
 
3.5.2.6. Season vs. c-ELISA Result Cross tab: 
4.1% positive reactions exhibited during the dry season which 
increased to 12.4% during the rainy season by the c-ELISA. (Table No. 12.). 
Pearson Chi-Square test showed a highly significant relationship, the value 
was (0.000). 
 
3.5.2.7. Vaccination vs. c-ELISA Result Cross tab: 
3.1% of the c-ELISA positive samples appeared in the vaccinated 
cattle while increased to 13.4% c-ELISA positive samples in the Non-
vaccinated cattle. (Table No. 13.). Pearson Chi-Square test showed weak 
significant relationship, the value was (0.620) 
 
Table No. 7. Vaccination  Status vs. CFT Result Cross Tabulation. 
 
 
 
 
 
Crosstab
13 39 2 54
2.9% 8.8% .5% 12.2%
102 260 27 389
23.0% 58.7% 6.1% 87.8%
115 299 29 443
26.0% 67.5% 6.5% 100.0%
*
*
*
Vaccinated
Non-Vaccinated
Vaccination
Total
Positive Negative Doubtful
CFT-Result
Total
 
 
*Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 8. Samples Collection Year vs. c-ELISA Results Cross 
Tabulation. 
 
 
 
Crosstab
11 167 38 216
3.4% 52.2% 11.9% 67.5%
42 60 2 104
13.1% 18.8% .6% 32.5%
53 227 40 320
16.5% 71.0% 12.5% 100.0%
*
*
*
2003
2004
Sample collection year
Total
Positive Negative Doubtfull
ELISA-Result
Total
 
 
* Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 9. Locations of Samples vs. c-ELISA Results Cross 
Tabulation. 
 
 
 
Location of Samples vs. C-ELISA Crosstabulation
1 49 14 64
.3% 15.3% 4.4% 20.0%
42 60 2 104
13.1% 18.7% .6% 32.6%
8 88 11 107
2.5% 27.5% 3.4% 33.4%
.00 7 5 12
0% 2.2% 1.6% 3.7%
2 23 8 33
.6% 7.2% 2.5% 10.3%
53 227 40 320
16.6% 70.9% 12.5% 100.0%
*
*
*
*
*
*
Rubkona
Thoan
Kilo 15, Kilo 30 & Mala
Gamos & Mirmir
Munga & Abyamnam
Location of Samples
Total
Positive Negative Doubtfull
ELISA-Result
Total
 
 
* Indicates Percentages. 
 
 
 
 
 
 
 
 
 
Table No. 10. Sex vs. c-ELISA Result Cross Tabulation. 
 
 
 
 
 
Crosstab
9 21 2 32
2.8% 6.6% .6% 10.0%
44 206 38 288
13.7% 64.4% 11.9% 90.0%
53 227 40 320
16.5% 71.0% 12.5% 100.0%
*
*
*
Male
Femal
Sex of Animal
Total
Positive Negative Doubtfull
ELISA-Result
Total
 
 
* Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 11. Breed vs. c-ELISA Result Cross Tabulation. 
 
 
 
 
Crosstab
51 203 32 286
15.9% 63.5% 10.0% 89.4%
2 24 8 34
.6% 7.5% 2.5% 10.6%
53 227 40 320
16.5% 71.0% 12.5% 100.0%
*
*
*
Nilotic
Baggara
Breed
Total
Positive Negative Doubtfull
ELISA-Result
Total
 
 
* Indicates Percentages.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 12. Season of Samples collection vs. c-ELISA Result Cross 
Tabulation. 
 
 
 
 
Crosstab
13 103 15 131
4.1% 32.2% 4.7% 41.0%
40 124 25 189
12.4% 38.8% 7.8% 59.0%
53 227 40 320
16.5% 71.0% 12.5% 100.0%
*
*
*
Dry season
Rainy season
Season of the sample collection
Total
Positive Negative Doubtfull
ELISA-Result
Total
 
 
* Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table No. 13. Vaccination Status vs. c-ELISA Result Cross Tabulation. 
 
 
 
 
Crosstab
10 32 9 51
3.1% 10.0% 2.8% 15.9%
43 195 31 269
13.4% 61.0% 9.7% 84.1%
53 227 40 320
16.5% 71.0% 12.5% 100.0%
*
*
*
Vaccinated
Non-Vaccinated
Vaccination
Total
Positive Negative Doubtfull
ELISA-Result
Total
 
 
 
* Indicates Percentages. 
 
 
 
 
 
 
 
 
 
 
 
 
3.5.3. CFT vs. C-ELISA Results Comparison: 
 
3.5.3.1. Results: 
The Positive reaction by the CFT was 26% while 16.6% by c-ELISA.  
The Negative reaction by the CFT was 67.5% while 70.9% by c-ELISA.  
The Doubtful reaction by the CFT was 6.5% while 12.5% by c-ELISA. 
(Table No. 14). 
 
3.5.3.2. Year: 
In 2003 the Positive Result by CFT was 3.4% and 13.1% by c-ELISA. 
while in 2004 the Positive Result by CFT was 11.3% and 14.7% by c-
ELISA. (Table. No.14). 
 
3.5.3.3. Location: 
The location vs. CFT and c-ELISA Results Cross Tabulation showed 
a significant relationship by the CFT with value (80.710) and highly 
significant relationship by the c-ELISA with value (287.034) both compared 
with Pearson Chi-Square test.  
 
3.5.3.4. Sex: 
Sex of sampled animals vs. CFT and c-ELISA result cross tabulation 
checked by Pearson Chi-Square test showed a weak significant relationship. 
 
3.5.3.5. Breed: 
Breed of sampled animals vs. CFT and c-ELISA results cross 
tabulation revealed Moderate significant relationship with CFT and Highly 
significant relationship with the c-ELISA by Pearson Chi-Square test. 
3.5.3.6. Season: 
Season of sample collection vs. CFT and C-ELISA result cross 
tabulation checked by Pearson Chi-Square test showed highly significant 
relationship in both tests. 
 
3.5.3.7. Vaccination: 
Vaccination vs. CFT and C-ELISA results cross tabulation revealed No 
significant relationship with the CFT and a highly significant relationship 
with the c-ELISA by Pearson Chi-Square test. 
 
3.6. Participatory Epidemiology: 
 
3.6.1. Direct Observations: 
The Nuer community used to collect  the cattle dung and then burned 
it at night times creating smokes to prevent their cattle from the biting flies 
and ticks this might be indoors or outdoors. Ashes were used topically to 
prevent cattle from insects and ticks. In the villages the cattle were kept 
inside big huts called (Al Wak) at nights. Traditional cattle exchange is a 
common practice in the Nuer community (Marriages, Compensations etc.). 
 
3.6.2. Interviews: 
Doap is the local name for CBPP as referred by the different Nuer 
groups, which means pain in the chest. The Nuer informants mentioned a 
seasonal mode for CBPP especially during the rainy seasons. Nuer 
informants reported that some sick cattle may recover from Doap (CBPP) if 
an antibiotic was used. Nuer informants did not practice vaccination against 
epidemic diseases before but part of them reported that they had practiced 
vaccination before during Pan African Rinderpest Campaign (PARC) 
mission in the 1990s. Vaccinated cattle had notched ears. 
The Messeria informants reported that they practice vaccination annually in 
their origin states (Western and Southern Kordofan) against Anthrax, H.S 
and B.Q but not against CBPP in particular. 
 
3.6.3. Mapping: 
The Nuer groups and the Messeria groups illustrated their grazing, 
watering areas and the surrounding areas and their cattle movement paths. 
  
3.6.4. Seasonal Calendars: 
The majority of the Nuer informants stated that the disease Doap 
(CBPP) was observed after the rainfalls, part of the informants stated that 
disease may appear during the dry season when the cattle gathered together 
at the watering points. 
 
3.6.5. Ranking, Scoring and Proportional Piling:  
Nuer informants agreed on the ranking of the most common diseases 
in the areas as follow: FMD, H.S, Trypansomiasis, CBPP and brucellosis.   
Although the informants mentioned a relationship between the biting flies 
and  the transmission of Trypansomiasis but they considered it as one of the 
common diseases in the area. 
The Nuer groups applied proportional piling for the above ranked diseases 
and they mentioned the prevalence and the importance of each disease. 
Messeria informants did not mention CBPP as one of their major cattle 
diseases in their areas but they mentioned that their cattle may catch CBPP 
infection if get in contact with Nuer cattle. (Figure No.6.).  
Table No.14. CFT Results vs. c-ELISA Results and Percentages by 
Locations. 
 
 
 
 CFT Results C-ELISA Results 
Location Positive Negative Doubtful Positive Negative Doubtful
Rubkona 9.3% 23.7% 3.6% 0.3% 15.3% 4.4% 
Thoan 11.3% 11.3% 2.0% 13.1% 18.7% 0.6% 
K-15, k-30 and Mala 3.1% 21.2% 0.9% 2.5% 27.5% 3.4% 
Gamos and Mirmr 1.3% 4.1% 0.0% 0.0% 2.2% 1.6% 
Munga and 
Abyamnam 
1.0% 7.2% 0.0% 0.6% 7.2% 2.5% 
Total 26.0% 67.5% 6.5% 16.6% 70.9% 12.5% 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure.No.6. Proportional Piling for Ranked Bovine Diseases by Nuer. 
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CHAPTER FOUR 
DISCUSSION 
 
The analysis of the clinical data which was obtained from WN-
POC/CD vet-clinics showed that major infectious diseases in the area were: 
Respiratory infections, FMD, H.S, Brucellosis, CBPP and B.Q.  
The study covered most parts of Unity State, Southern Sudan and tested 
cattle from both Nuer and Messeria ethnic groups. 
The Nuer tribe is the dominant tribe in the state through out the year 
this result was confirmed by the study; 91.9% of the tested cattle were 
Nilotic cattle breed which belonged to the Nuer tribe while 8.1% Baggara 
cattle breed that belonged to the Messeria tribe who spent the dry season 
grazing and watering their cattle inside the state territories coming from 
Western and Southern Kordofan states.  
The approaching of the Messeria tribe to the state exposed their cattle to the 
endemic diseases in the area and spreading their diseases as well. 
The majority of the samples 69.5% were collected from Nuer cattle 
camps during the rainy season when they assembled their cattle in the 
highlands between the swamps. 
In the study 87.2% of the sampled animals were never been vaccinated 
before, vaccination coverage was very low 12.2% among the tested animals; 
4.1% for Nilotic cattle breed and 8.1% for Baggara cattle breed owned by 
the Messeria tribe. 
Vaccination in general and particularly against CBPP was not 
practiced in Unity State due to insecurity, lack of logistic means and lack of 
technical support as the Animal Resources and Fisheries (ARF) director 
stated in the interviews.  
Part of Nuer informants stated that they never had vaccinated their cattle 
since the beginning of 1990 during the PARC mission and that was mainly 
against Rinderpest; they also stated that the vaccinated cattle have notched 
ears. The other part of informants indicated that they had never practiced 
cattle vaccination before. 
The Messeria tribe informants stated that they practiced vaccination in 
their origin states; West and Southern Kordofan against H.S, Anthrax and 
B.Q but not against CBPP which is not common in their origin states. 
         During the study two cultures out of eight (25%) showed turbidity in 
the liquid media, later on a noticeable growth and fried egg shape colonies 
have been clearly recognized after 7 days on the solid media. 
        After that confirmatory tests by both Digitonin and Growth Inhibition 
tests were applied, both showed positive reactions. That confirmed the 
presence of the Mmm SC microorganism in the area. 
In this study Complement Fixation Test (CFT) results revealed that; 
(115) 26% out of the tested sera were positive, (29) 6.5% were doubtful and 
(299) 67.5% were negative via CF. Those results were similar to Mefit-
Babtie (1983) who reported the results of a small CFT serosurvey including 
123 Dinka, 24 Nuer and 52 Shilluk cattle and found 8%, 4% and 2% 
positive, respectively. Further, of 59 Dinka cattle reported to have a history 
of respiratory disease, 16 (27%) were positive by CFT. Out of 15 Dinka 
animals that had no history of respiratory, 0 (0%) were positive. Out of 59 
animals reported to have had respiratory disease (abut pio), 21 cases 
occurred in the year of testing, 32 one-year previously and 6 two-years 
previous. Out of those 8 (38%), 7(22%) and 1(16%) were positive, 
respectively.  
The CFT positive results illustrated in this study were increased 
rapidly from 3.4% during the year 2003 to 13.1% in the year 2004, those 
results my considered as an Early Warning System (EWS) indication of 
CBPP feasible outbreak due to the relative progresses in the  peace situation 
which increased  the number of cattle grazing in the study area.   
In this study the CFT suggested that 25.1% out of the positive results 
appeared in the Nilotic cattle breed while only 0.9% appeared in Baggara 
cattle breed, that may be due to the none existence of direct contact between 
the two breeds because of Bahr Algazal River. That was also an indication 
that CBPP is widespread among the Nuer cattle rather than Baggara cattle.  
In this study CFT exhibited 4.7% positive result during the dry season but 
increased to 21.2% during the rainy season suggesting a seasonal pattern for 
CBPP, which may be due to the stress factor caused by the assembling of 
large numbers of different herds in a limited flat terrain (highland) during 
the rainy season. The Nuer informants also mentioned that Doap (CBPP) 
appearance was associated with the rainy season.  
Those results resembled those of Zessin et al. (1985) who noted “Because 
the Dinka husbandry system makes animals rotate and circulate extensively, 
such an endemic state with ‘disease stability’ is readily reached”. Our 
informants indicated that CBPP was endemic with peaks of mortality during 
periods of stress such as the onset of the rains and the height of the dry 
season. The traditional exchange of livestock would indeed appear to 
facilitate the establishment and maintenance of endemic stability. 
2.9% of the CFT positive samples appeared in the vaccinated cattle, 
on the other hand 23% of the CFT positive samples occurred in Non-
vaccinated cattle. The presence of the CFT Sero-Positive reactors in 
vaccinated samples was due to natural infection and not residual antibodies 
from previous vaccination as the study suggested pear in mind that No 
vaccination against CBPP was particularly applied in this area. 
That result can be confirmed by (Campbell and Turner, 1953) who reported 
neither natural nor vaccinal CFT antibodies persist except in cases of severe 
reactions. Antibodies induced by vaccination are not detected by CFT for 
more than a few weeks (Campbell and Turner, 1953). 
In this study the Competitive Enzyme Linked Immuno Sorbent Assay 
results revealed that: (53) 16.5% of the tested sera were positive, (40) 12.5% 
were doubtful and (227) 71% were negative to c-ELISA. 
C-ELISA positive results revealed that 2.8% were males and 13.7%                
were females. 
The c-ELISA positive results illustrated in this study was slightly increased 
from 13.1% during the year 2003 to 14.7% in the year 2004 which was an 
indication of CBPP possible outbreak. 
In this study the c-ELISA suggested that 15.9% out of the positive results 
appeared in the Nilotic cattle breed while only 0.6% appeared in the Bggara 
cattle breed, indicating that CBPP was more common among Nuer cattle. 
In this study the c-ELISA exhibited 4.1% positive results during the 
dry season which increased to 12.4% positive during the rainy season 
suggesting a seasonal pattern for CBPP, which was well-matched with the 
seasonality of Doap (CBPP) as indicated by the Nuer informants group.  
This result is consistent with Hudson’s, (1968). Who reported that the 
organism is very sensitive to ultraviolet light and during daylight in hot 
sunny weather droplets may soon be rendered harmless. Close contact at 
night and during dull weather may be important in the spread of infection. 
In this study 3.1% of c-ELISA positive samples appeared in the vaccinated 
cattle while increased to 13.4% c-ELISA positive samples in the Non-
vaccinated cattle.   
In this study a comparison between the results which gained from the 
two serological tests (CFT and C-ELISA) recognized that there were 
obvious variations in the obtained results (Positive, Doubtful and Negative) 
from both tests. 
Sero-Positive Reactors obtained by CFT (26%) were obviously lesser than 
the positive ones by C-ELISA (16.5%).  
During the present study agreement between the positive results 
revealed by both CFT and C-ELISA was 63.5%, between the doubtful 
results revealed by both tests was 52% and between the negative results 
revealed by both tests was 95.1%.  
According to the doubtful results of both tests; c-ELISA doubtful results 
(12.5%) were noticed to be much higher than CFT doubtful results (6.5%). 
That led to miss detection of some CFT positive reactors by c-ELISA and 
that meant less positive results were detected by c-ELISA (16.5%) compared 
to CFT positive results (26%). 
Those results were justified by Amanfu et al., (2000). Who reported that the 
c-ELISA test has been developed more recently and data is much less 
comprehensive but it is believed to be comparable to the CFT in terms of 
sensitivity for chronic carriers but less sensitive than CFT for the detection 
of acute cases (Amanfu et al., 2000).  
Although the CFT false positive were possible as Hudson, (1971) who 
reported that the advantage of the CFT is the low number of false positive 
and negative reactions (Hudson, 1971). 
In this study both CFT and c-ELISA agreed on that most of the Sero-
positive results appeared in the Nilotic breeds (25.1%), (15.9%) while only 
(0.9%), (0.6%) appeared in the Baggara breed that may be due to the none 
existence of the direct contact between the two breeds but that will be an 
expected hazard in the future if both breeds graze near by each other. 
In this study the agreement between the c-ELISA and CF Sero-positive was 
63.5%. Although (Mia et al., 1993) reported 96% agreement between the 
CFT and c-ELISA tests over 300 positive and negative sera. Nevertheless a 
small number of sera from apparently healthy herds was positive in CFT but 
gave negative results in the c-ELISA and in both pathological and cultural 
examinations. 
At the present work most of the sero-positive samples CFT (22.8%) 
and c-ELISA (13.7%) were collected from females but that has No statistical 
significance as proved by Chi square test.  
With regards to participatory epidemiology approaches; Nuer 
informants mentioned the existence of Doap (CBPP) as well as the clinical 
signs in their cattle herds especially after the start of the rainy season, this 
information could be of a great value for CBPP surveillance.   
Those results are compatible with those of Zessin et al. (1985) who 
suggested that a targeted approach to CBPP control would be warranted 
based on a disease intelligence system that involved the livestock owners.  
In this study advantages and disadvantages of both CFT and c-ELISA 
were compared and evaluated from a practical point of view. 
CFT advantages; Complement fixing reactions were very obvious through 
the naked eye; results could be read directly or could be postponed 
overnight. 
Regards to CFT disadvantages; the test preparations and procedures were 
time consuming, the test needed very skilled personnel to be performed 
properly, the test was very complicated to be carried out at the field level 
and the reading of reactions could be affected by personal bias. 
Those results agreed partially with (Hudson, 1971) who reported that an 
advantage of CFT; low numbers of false positive and negative reactions. The 
main disadvantages of CFT are that it fails to detect animals in the 
incubation period of the disease. Regalla, (1995); Reported that CFT is the 
approved OIE test, although specific, lacks sensitivity. In addition, it 
requires highly trained staff to perform it accurately and consistently 
(Regalla, 1995). 
The c-ELISA advantages: Simple test, appropriate at field level, time 
saving, understandable results and nonexistence of personal bias. 
Regards to c-ELISA disadvantages: ELISA reader machine is a must, results 
might be lost unless been read instantly and existence of high range of 
doubtful results. 
The present advantages and disadvantages of C-ELISA results agreed to 
some extent with (Le Goff and Thiaucourt, 1998). Who reported that c-
ELISA may have advantages in terms of ease of testing and standardization 
of results, but it has sensitivity levels similar to CFT and thus will enable the 
persistence of disease as seen with CFT (Le Goff and Thiaucourt, 1998). 
 
 
 
 
 
 
CONCLUSIONS 
 
1. Contagious Bovine Pleuropneumonia is one of the major infectious 
cattle diseases in Unity State together with FMD, H.S, Brucellosis and 
B.Q. 
2. The presence of CBPP has been confirmed in Unity State through 
Bacteriological, Serologically and Participatory Epidemiology 
techniques.  
3. CBPP was found to be more common among the Nilotic cattle breed 
rather than Baggara cattle breed with an obvious seasonal onset. 
4. The Complement fixation Test (CFT) was found to be more 
successful in investigating CBPP and results were obvious but the test 
was very complicated and rigid to be executed at the field level. 
5. The Competitive Enzyme Linked Immuono Sorbant Assay was found 
to be useful, straightforward but has a high range of doubtful results 
and that may affect the validity of the test. 
6. Participatory Epidemiology Approaches were found to be practical 
and useful in terms of anticipating CBPP outbreaks and enriching the 
Ethno Veterinary Knowledge (EVK).  
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Figure No. 2.  Pie Chart demonstrates the sex distribution among 
samples.  
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Figure No. 3. Pie Chart demonstrates Types of Sampled Cattle Breed.  
 
 
 
 
 
 
  
 
 
 
Season of the sample collection
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Figure No. 4. Pie Chart illustrates Seasons of Sample Collection. 
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Figure No. 5. Pie Chart illustrates Vaccination Coverage Percentages 
among the Sampled Animals. 
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Figure No. 9.  Pie Chart demonstrating the Percentages of the Collected 
Serum Samples in 2003 and 2004.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CFT-Result
6.5%
67.5%
26.0%
Doubtful
Negative
Positive
 
 
Figure No. 11. Pie Chart demonstrating Percentages of CFT Results. 
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Figure No. 12. Pie Chart Demonstrating c-ELISA Results Percentages.  
 
 
 
 
 
 
 
 
 
Table No. 15 Prevalence and Importance of Major Cattle diseases 
Ranked by Nuer Ethnic Groups in Different Locations of Unity State.  
 
 
 
Disease 
Liei 
(Trypanosomia
sis + Internal 
Parasites) 
 
Dat 
(FMD) 
Doap 
(CBPP) 
Yeithpin 
(Haemorrhagic 
Septicaemia) 
Mullaeh 
(Brucellosis) 
Location Prev. Imp. Pre
v. 
Imp
. 
Prev
. 
Imp
. 
Prev. Imp. Prev
. 
Imp. 
Rubkona 
 
33 20 22 44 21 11 19 20 6 5 
Thoan 24 20 20 27 14 22 29 25 14 6 
K15, K30 and 
Mala 
13 8 32 20 10 10 35 55 10 7 
Mirmir 27 
 
23 29 30 16 17 20 22 8 8 
Khor Gamos 16 
 
20 26 30 33 17 16 20 9 10 
Munga and 
Abyamnam 
10 16 29 41 15 07 31 25 15 11 
Means   20.5  17.8 26.3 32 18.2 14 25 27.8 10.3 7.8 
Medians  20 20 27.5 30 15.5 14 24.5 23.5 9.5 7.5 
 
 
 
